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INTRODUCTION
1. Herpes Simplex Virus 1
1.1 Epidemiology
Herpes Simplex Virus Type 1 (HSV-1) is a common existing virus that is known
to cause infection in the majority of the world’s population [1,2,3]. HSV-1 can establish
latency with the potential to cause recurrent disease in the host for a lifetime [4]. In the
United States, 50% of the total population has been estimated to be seropositive for
HSV-1, while in Asia and Europe reported a higher incidence of HSV-1 infection, as
high as 80% [5,6,7]. The reports of HSV-1 infection across the world explicitly
demonstrates its ubiquitous prevalence. Approximately, 20,000 new cases appear
annually with an increased risk in children and aged individuals (45-49yr old) [5,8].
HSV-1 primarily infects the orofacial region causing skin lesions (cold sores)
[9,2]. During latency, HSV-1 harbors in the trigeminal ganglion and acquires a quiescent
latency mode in the absence of infectious virions [10]. Reactivation of HSV-1 can lead
to ocular infections causing blindness [11,12]. Herpes Stromal Keratitis (HSK) is the
leading cause of corneal blindness in the United States [11]. Corneal epithelial defect
and stromal inflammation cause corneal blindness, that obscures the clear vision during
the pathogenesis of HSK [13]. Contemporary therapeutics such as anti-viral (acyclovir)
and anti-inflammatory (corticosteroid) drugs have been shown to control the disease
transiently but cannot subdue the HSK disease severity. Therefore, an urgent need for a
promising cure is crucial to treat HSK causing corneal blindness.
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1.2. HSV-1 Structure and Lytic Life Cycle
HSV-1 is a double-stranded DNA virus encapsulated within an icosahedral
nucleocapsid consisting of 162 capsomeres [14,15]. The HSV-1 viral genome encodes
84 proteins that play a major role in the lytic life cycle of the virus. The first step of the
lytic cycle is the entry of the HSV-1 virus into the host cell which is initiated by the
attachment and fusion of the virus to the host cell surface proteins (heparan sulfates).
There are several glycoproteins namely, gB, gC, gD, gH, and gL that are involved in its
interaction with the host cell surface receptors [16]. Nectin-1, herpes virus entry
mediator (HVEM), and paired immunoglobulin-like type 2 receptor-alpha (PILR-α)
receptor on the corneal epithelium has been reported to be the key receptors which help
in the HSV-1 viral entry [17,18]. Furthermore, upon the entry of the virus into the host
cell, the transcription machinery for viral DNA replication and assembly of new viral
capsids will occur following the insertion of the viral genome into the host nucleus [19].
Consequently, the host cell machinery will aid in the expression of immediate early (IE),
early (E), and the late (L) proteins required for the synthesis of new virions [20,21].
Finally, a newly synthesized DNA will be packaged into a nucleocapsid to form a
complete virion [22].
An interesting aspect of the HSV-1 life cycle is its establishment of latency in the
trigeminal ganglion. Once the active viral replication subsides, the viral genome remains
in the infected host cell, thereby maintaining the virus in the latent phase [23,24]. The
expression of latency associated transcripts promotes the HSV-1 latency [25]. There are
ongoing studies to understand further the factors associated with the establishment and
maintenance of HSV-1 latency in the trigeminal ganglion.

However, reports have
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suggested that stress can induce a shift from latent to the lytic cycle (active replication)
of the HSV-1 virus which can lead to catastrophic conditions in the host. Notably, In the
mouse model of HSK, the disease is not induced by the virus reactivation, since the
cornea is the primary site of infection that favors being a good model to study the
pathology of the disease similar as in humans.
1.3. Pathogenesis of Herpes Stromal Keratitis
1.3.1. Pre-clinical Phase
Development of HSK in the mouse models is very similar to the events that take
place in the human eyes. However, in mouse model primary HSV-1 infection is
conducted by directly infecting the cornea. While in human eyes the majority of HSV-1
infection occurs via reactivation of the virus, termed as the recurrent infection.
Pathogenesis of HSK can be broadly categorized into the pre-clinical and the clinical
phase (Figure 1). The preclinical phase lasts through 7 days post-infection, after which
the clinical phase of HSK will commence which is responsible for the development of
corneal pathology (Figure 1).
In the pre-clinical phase of the HSK disease, the active replication of the virus is
controlled by the innate immune response [26,27]. This response is induced by the
influx of early innate immune cells such as neutrophils, macrophages and dendritic cells
for the initial attempt to clear the virus [28]. The innate immune cells can secrete
mediators such as tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), nitric oxide and
other reactive oxygen species that can aid in virus clearance but, can subsequently
damage the corneal tissue causing detrimental effects [29]. A plethora of proinflammatory factors is released by the innate immune cells such as Interleukins (IL-1,
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IL-6, IL-8, IL-12) and macrophage inflammatory proteins (MIP-1α) [30]. Neutrophils are
the short-lived cells that survive 2-3 days post HSV-1 infection in cornea [31].
Neutrophils play an essential role in viral clearance via phagocytosis of the virus and by
the release reactive oxygen species (ROS). Meanwhile, the antigen presenting cells
pick up these phagocytosed viral particles to elicit the T-cell responses. Consequently,
this promotes the onset of the clinical phase in the HSK pathogenesis.
1.3.1. Clinical Phase
In mouse models of HSV-1 infection, the clinical phase will commence after 8-9
days post infection. During this phase, characteristic features of HSK pathogenesis will
appear in the infected cornea, such as the development of hem-angiogenesis, and
corneal opacity which leads to corneal damage and blindness. T-cells have been
reported to be the major cell types responsible for the HSK disease severity.
Interestingly, studies have demonstrated that the lack of T-cells will not promote the
development of HSK disease [32,33]. CD4+ T cells play a predominant role in secreting
pro-inflammatory factors and chemotactic signals to help the extravasation of the
polymorphonuclear cells (PMNs) [30,34].
Of note, the influx of neutrophils occurs during the clinical phase, causing a
biphasic response during HSK disease progression [35,36]. Apart from the T-cells, the
second wave of neutrophils influx is also responsible for the HSK disease severity.
Surprisingly, the infiltrated neutrophils in the second wave are resistant to apoptosis
[31]. Eventually, the existence of neutrophils for an extended period in the infected
cornea will cause increased corneal tissue damage [37,38]. To moderate this immuno-
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inflammatory condition, there are anti-inflammatory molecules and neuropeptides
produced from the corneal sensory nerve stimulation) [39,40,41]
2. Cornea
2.1. Structure of normal cornea and tear film
The cornea is a unique avascular and a transparent tissue that not only protects
the anterior ocular surface but also aids in clear vision. Normally the corneal surface
maintains its moist and smooth refractive surface in the presence of trilaminar tear film
with a thickness of about 4-6μm. It is composed of lipid, aqueous and mucin layers [42],
(Figure 3). Tear film also plays a role in supplying the cornea with nutrients and
protecting the ocular surface from invading pathogens [43,44]. Tear film (Figure 3)
consists of the outer lipid (oil) layer produced from meibomian glands (modified
sebaceous glands) located in the tarsal plates [45]. Meibum consists primarily of
phospholipids and maintains its fluidic property, due to its low melting temperature. It
acts like a surfactant that spreads over the aqueous layer of tear film [46]. Hence, the
absence of a meibomian layer results in evaporation of tear film [47]. The middle
aqueous layer of tear film comprises 90% of the tear film and consists of water,
electrolytes, and proteins [48]. It is produced mostly from lacrimal glands that contain
soluble mucins which contribute to the viscosity of the tear film. The middle aqueous
layer functions in not only providing lubrication, protecting from foreign materials but
also in delivering nutrients such as oxygen, glucose, and proteins to the underlying
corneal tissue [49].The innermost mucus layer is secreted by the conjunctival goblet
cells, in addition to corneal and conjunctival epithelium [50]. This layer consists of ocular
mucus composed of primarily the mucins that protect, lubricate and anchor aqueous
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tear film to the underlying corneal epithelium. Mucins are high molecular weight
glycoproteins located on the apical surface of the epithelium [51]. There are two classes
of mucins, which includes a secretory and membrane-bound form [52]. The secretary
form of mucin further consists of two forms, the large gel-forming mucin and the small
soluble mucin [44,53,54]. MUC5AC is one of the major large gel-forming mucin
expressed in conjunctival goblet cells. The secreted forms of mucins lack a
transmembrane domain which is produced by the goblet cells [55]. In contrast, the
membrane-bound mucins have a short cytoplasmic tail with a single transmembrane
domain and a glycosylated extracellular domain. The corneal and conjunctival epithelial
cells contain membrane-bound mucins namely, MUC1, MUC4, and MUC16 that
functions to form glycocalyx at the epithelial cell-tear film interface [56]. The glycocalyx
protects corneal epithelium from shear forces or desiccation [57]. The corneal and
conjunctival epithelium is covered by microvilli, microplicae, and glycocalyx composed
of glycoproteins and glycolipids [50,58,59]. The glycocalyx extends between microplicae
and microvilli through branching and associates itself to the epithelial cell membrane
and also assists in binding to the mucus layer [60]. Hence, the mucus layer binds to the
glycocalyx and moves freely across the cornea without firmly attaching itself to the
corneal epithelium [61]. Glycocalyx helps in even spreading of the mucus across the
corneal epithelium. However, deficiency in tear film production or increased tear
evaporation causes dry eye conditions leads to corneal epithelial damage [52].
Structurally cornea is comprised of five morphologically distinct layers (Fig 2) that
includes (a) corneal epithelium (b) Bowman’s layer, (c) stroma, (d) Descemet’s
membrane and the (e) endothelium. The three major functional layers include the
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anterior corneal epithelium, middle tough collagenous stroma and the posterior
monolayer of the endothelium [62].
Corneal epithelium (Figure 2) is 50-70μm thick and is derived from the surface
ectoderm during embryogenesis [63]. Corneal epithelium consists of 5-6 layers of
nucleated cells, which can be further subdivided into three layers, (i) surface cell layer
(ii) wing like cell layer (iii) Basal layer. The apical (surface) layer is a 2-3 layer with
stratified

squamous

non

keratinized

epithelium

that

exhibits

surface

microvilli/microplicae that contacts with the ocular mucins [63,64]. It is also a protective
layer, as it continuously shed cells. The middle wing-like the cell layer is 1-2 layers with
polyhedral shaped cells. The deeper basal cell layer is the germinative layer of the
corneal epithelium which consists of columnar cells. The corneal epithelium is devoid of
goblet cells and is continuous with the conjunctival epithelium at the limbus [65,66].
Corneal epithelial cells are actively metabolizing cells with abundant mitochondria
present in the wing like cells but scarce in the basal layer, while the wing like cells and
the surface cells contain rich glycogen deposits [64] Junctional complexes, such as tight
junction proteins (Zonula occludens-1, occludens, claudin-1) desmosomes, and
intermediate filaments play a major role in maintaining corneal epithelial cell integrity
and polarity [66]. Epithelial cells express intermediate filament proteins with their diverse
expression depending on the location and differentiation pattern [67]. These filaments
are formed by the pairing of type-1 (acidic) and type-II molecules (basic/neutral) in a 1:1
ratio. Cytokeratins function in maintaining epithelial integrity, mechanical stability and
regulating intracellular pathways such as wound healing/apoptosis [67,68]. Stability of
epithelial cells is maintained by cytokeratins through their interaction with the
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desmosomes and the hemidesmosomes between the epithelial cells and to the
basement membrane. Since the expression pattern of cytokeratin sheds light on the
differentiation pattern of the epithelium, it is used as a potent epithelial differentiation
marker, as well as a diagnostic tumor marker [67,69]. Corneal epithelial cells express
K3 (type II)/K12 (type I) pair in all layers of the epithelium, and the suprabasal cells of
the limbus region are also positive to K12. In contrast, the basal corneal stem cells in
the limbus region are both K3/K12 negative [70,71]. Apart from the corneal epithelium,
the conjunctiva is also known to express K15 in all layers of its epithelium with K19
expression in its basal layer only [72].
A fragile detachable epithelium characterizes an absence of cytokeratin
expression in the corneal epithelial cells due to its loss of mechanical stability [73,74].
Interesting findings from several reports show that during corneal insults the expression
pattern of cytokeratin changes; for ex: 1) debrided corneal epithelium showed K19/K15
expression with the appearance of goblet cells, that signifies the alteration into
conjunctival type of epithelium [72]; 2) Dry eye conditions showed corneal epithelium
with K1/K10 expression, signifying its alteration to skin type of epithelium (nonkeratinized to keratinized type). These conditions are correlated with the development of
‘squamous metaplasia’ in the corneal epithelium that is characterized with the
keratinization, loss of mucin expression, increased stratification of cells and
enlargement of the surface squamous cells [75].
Corneal stroma (Figure 2) is protected by the overlying dense collagenous
Bowman’s layer. Stroma is the largest and the thickest (400-500μm) layer of the cornea
that consists of specialized collagen fibers- ‘lamellae.’ A defined organization of the
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lamellae contributes to corneal transparency. The lamella is interspersed with
keratocytes and ground substance (proteoglycans and chondroitin sulfate) that plays a
role in maintaining the corneal matrix. During corneal wounding, keratocytes undergo
differentiation to form fibroblast cell type with a capability to migrate to the wound site in
the presence of contractile actin element and subsequently to myofibroblast phenotype
of cells with an increased contractile ability due to the expression of α-Smooth Muscle
Actin (α-SMA). During pathological conditions, corneal epithelial cells, are known to
secrete growth factors such as transforming growth factor (TGF-β1), epidermal growth
factor (EGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF-1), which
binds to their cognate receptors to mediate signal transduction pathways that can alter
the normal phenotype of the corneal stroma [64,76].
Corneal endothelium (Figure 2) consists of a monolayer of non-dividing cells
with a limited regenerative capacity. It mainly functions as a pump between the anterior
cornea and the posterior aqueous humor to deliver waste out and diffuse nutrients into
the cornea [63].
2.2. Corneal nerves
The cornea is an avascular tissue; however, it is also a densely innervated
tissue. Corneal nerves play an essential role in tear production and secretion.
Additionally, corneal nerves help in wound healing, the blink reflex, and sensations of
temperature, pain, and touch [77]. It is well known from literature studies that corneal
nerve dysfunction leads to corneal opacity and loss of vision [78]. Approximately 1.57
million people worldwide have blindness due to corneal opacity [78]. Corneal nerve
damage may also occur under inflammatory conditions or in the presence of an
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infectious corneal disease leading to blindness [79]. From a recent study, it has been
demonstrated that HSV-1 infection in cornea leads to corneal nerve degeneration [80].
Hence, this makes it important to understand the structure and function of corneal
nerves.
The ophthalmic branch of cranial nerve V (trigeminal nerve) branches into
sensory trigeminal neurons to transmit nerve fibers in the cornea and terminate into free
nerve fiber endings in the corneal epithelium [81]. The nerve fibers from the trigeminal
ganglion cells branch to form nerve bundles near the limbus. These nerve bundles now
form the limbal plexus [82]. From the limbal plexus, stromal nerve trunks emerge to
enter the peripheral corneal stroma in a radial pattern and divides into several branches
[83]. There are both unmyelinated and myelinated axons in the stromal nerve trunks
[84]. In the periphery of the mouse cornea there are myelinated nerve fibers, whereas,
in the periphery and central human cornea, beaded fibers and straight fibers are present
that are not myelinated and myelinated respectively [82,85].
Interestingly, corneal nerve fibers lose their myelin sheath with their outer
covering ‘perineurium’ only surrounded by Schwann cells that help in conducting nerve
impulses in the absence of myelination [86]. In the corneal stroma, as the nerve density
increases anteriorly, the diameter of the nerve also decreases making it thin and leading
to its branching into smaller fascicles eventually forming the anterior stromal plexus
[81,87,88]. Corneal stromal nerves are known to innervate keratocytes and are
organized in parallel to collagen lamellae, while only a few stromal nerves are known to
terminate as free nerve endings [88]. Defasciculation of stromal nerves may occur as
they reach the anteriormost of the stroma and into the subbasal nerve plexus reaching
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into the corneal epithelium. Hence, the innervation in the corneal epithelium is derived
from the subbasal nerve plexus, which originated from the branches of the peripheral
stromal nerves [89,90]. In the peripheral cornea, the tips of the stromal nerve enter and
gives rise to the long bundles of nerves that run into the central cornea, that eventually
divides into intricate branches to form a network in the corneal epithelium. The fashion
in which the nerves run into the cornea gives it a form called ‘swirl- like pattern’
[83,91,92]. The beaded unmyelinated nerve fibers run through the subbasal plexus and
terminate into the corneal epithelium as free nerve endings, especially with more dense
nerve endings in the central cornea [87]. The nerve fibers of corneal epithelium are
nociceptive fibers that respond to heat, chemical or mechanical stimuli [93]. A response
to neuropathic pain may also be associated with corneal inflammation [94]. Intriguingly,
the existence of neurotrophic factors in the cornea is known to maintain a healthy
corneal surface by modulating inflammation and inducing wound repair [95]. Some of
the corneal neurotrophic factors include nerve growth factor (NGF), Semaphorin (Sema)
3A, 3F, and 7A, Slits 1-3, Netrin 2, Ephrin (Eph) B2, Substance P (SP), calcitonin-gene
related peptide (CGRP), neurotrophin (NT-3) and brain-derived neurotrophic factor
(BDNF) [96,97]. Substance P is known to be released from the nerve fibers during
inflammation to promote wound healing and proliferation of corneal epithelial cells [95].
Therefore, the absence of neurotrophic factors can significantly affect the corneal nerve
function.
To study corneal nerve function, there are indirect tests performed such as; a)
lacrimation tests, for ex: the Schirmer and phenol red thread tests that assess the tear
production & quantification of tear volumes, b) Tests with vital dyes, for ex: fluorescein,
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Rose Bengal and lissamine green to observe the occurrence of corneal epithelium
damage [98]. Corneal diseases can be associated with the dysfunction of the corneal
nerves since the corneal sensory nerves are connected to the central nervous system
(brain) via afferent nerves while the signals from the brain are received through efferent
nerves [81]. Apart from the cornea, corneal sensory nerves, and brain, this circuit
system also comprises the lacrimal glands which complete the neural circuit and has an
essential role in tear production. Hence indirectly, during corneal damage, malfunction
of the neural circuit system can cause aberrant tear production. The absence of
neuropeptides involved in signaling the neural circuit can also cause a direct effect on
aberrant tear production [99]. It is evident that corneal nerves play an important role in
maintaining the corneal integrity since damage caused to corneal nerves leads to its
structural damage for ex: epithelial defect, perforation and reduced transparency
[100,101]. It is well known from a recent mouse model study that during HSV-1 infection
in the cornea, the damage is caused to the sensory nerve fibers innervating cornea that
as observed by the corneal whole mount staining for β-III tubulin (neuronal marker) [80].
Interestingly, another factor known to involve in corneal nerve formation is the
Paired box-6 (Pax-6). Pax-6 is a transcription factor that plays a major role in eye
development including the corneal epithelium. Deficiency in Pax-6 expression results
into various ocular anomalies, especially leading to corneal opacity, corneal epithelial
defects, vascularization and discrepancy in the regular corneal nerve pattern [102]. Pax6 has also been reported in maintaining normal corneal morphogenesis by controlling
the cellular adhesion in corneal epithelial cells via the expression of tight junction
proteins [103]. Therefore Pax-6 has been identified as a role model in keeping a normal
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healthy corneal epithelium that also functions in maintaining the corneal nerve
formation.
2.3. Corneal hem-angiogenesis
Corneal hem-angiogenesis involves the sprouting of new blood vessels from
capillaries and venules of pericorneal plexus of the limbal area that receives blood
supply from the branches of ophthalmic arteries and ciliary arteries [104]. The process
of corneal angiogenesis can be divided into several phases as follows; 1) the release of
growth factors under corneal injury and their binding to the cognate receptors present
on vascular endothelial cells. These cells belong to the neighboring pre-existing blood
vessels that help in promoting vessel growth. 2) Vascular endothelial cells undergo a
process of ‘activation’ after migrating away from the parent blood vessel by producing
proteolytic enzymes to degrade the basement membrane and extracellular matrix. 3)
Activated vascular endothelial cells acquire the expression of cell surface adhesion
molecules such as integrins and selectins [105].
The cornea under normal conditions, lacks both lymphatic and blood vessels,
thus maintaining its transparency and visual acuity [106]. An important characteristic
feature of the normal cornea is to maintain lymphatic and avascularity that also
influences the “immune privileged” status of the tissue. The privileged status of cornea
actively plays a role in maintaining a proper balance between angiogenic and antiangiogenic factors in corneal epithelium [104]. Several angiogenic molecules have been
identified to be expressed in the cornea, most prominently being Vascular endothelial
growth factor (VEGF-A also called as VEGF) which is increased during inflammation
and vascularization of the cornea in both human and animal models [104]. VEGF was
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initially named as vascular permeability factor (VPF) for its role as a stimulator of
vascular permeability. VEGF plays a crucial role in angiogenic events during embryonic,
physiologic, and pathological blood vessel growth in vivo104. VEGFs belong to a family
of secreted polypeptides with VEGF-A as a primary member of the family [104,107].
Additionally, VEGF-B, VEGF-C, and VEGF-D are the other members of the family that
differentially bind to VEGF receptors (VEGFR). VEGF-A binds to VEGFR-2 (also called
Flk-1) and VEGFR-1 (also called Flt-1), VEGF-C and VEGF-D bind to VEGFR-3 while
VEGF-B only binds to VEGFR-1 [104]. Recent studies have shown the expression of
VEGF localized to corneal epithelial and endothelial cells, vascular endothelial cells of
limbal vessels and keratocytes [104,105]. Normal cornea constitutively expresses
VEGFR-1 that binds to VEGF-A a potent angiogenic stimulator and VEGFR-3
specifically by corneal epithelium that binds to angiogenic VEGF-C and VEGF-D.
Additionally, there are also other critical anti-angiogenic molecules expressed by
corneas such as thrombospondin-1 (TSP-1), endogenous IL-1 receptor antagonist (IL1Ra) and Tissue inhibitor of metalloproteinases (TIMPs)-1 and 2. Therefore, these
factors help in maintaining corneal avascularity by inhibiting both hem-angiogenesis and
lymphangiogenesis. However, under inflammatory conditions such as HSK, increased
expression of VEGF has been reported, particularly by the epithelial cells of both
inflammed and vascularized cornea [108].
3. Hypoxia Inducible factor
3.1.HIF Pathway
Identification of hematopoietic growth hormone EPO led to the discovery of HIF
as a key regulator of hypoxia’ that can either directly or indirectly regulate gene
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expression involved in controlling metabolic adaptations, erythropoiesis, angiogenesis,
apoptosis and other cell survival processes [109]. HIF is a widely known transcription
factor with three different alpha isoforms namely HIF-1α, HIF-2α, and HIF-3α all that are
sensitive to oxygen tension; while the HIF-1β isoform is constitutively expressed. HIF-1β
is not oxygen responsive and forms heterodimeric complexes with one of the alpha
isoforms. Both HIF-1α and HIF-2α play a major role in upregulating angiogenic factors
during hypoxia [110]. Under normal oxygen tension (normoxia) HIF undergoes a
hydroxylation process. In contrast, under hypoxic conditions, HIF stabilizes in the
nucleus forming a heterodimer with HIF-1β that triggers the activation of genes involved
in both physiological and pathological conditions [111].
HIF-1β is constitutively expressed and forms a heterodimeric complex with one of
the three isoforms of HIF namely, HIF-1α, HIF-2α, and HIF-3α which are upregulated
during hypoxia [112]. Each of these alpha isoforms contains functional domains, with an
individual specific role in dimerization (bHLH/PAS), nuclear localization signal (NLS),
protein stability (ODDD-N-TAD), and transcriptional activity (N-TAD/C-TAD); bHLH –
basic helix loop helix domain; PAS= Per-Arnt-Sim motif; NLS= nuclear localization
signal;

ODDD=

oxygen-dependent

degradation

domain;

N-TAD=

N-terminal

transactivation domain; C-TAD= C-terminal transactivation domain [113]. Prolyl
hydroxylase enzymes (PHD1-3) play an important role in regulating the HIF pathway
since it functions as the oxygen sensor in the cells [114]. During normoxia, PHD
enzyme hydroxylates ODDD of HIF-α that initiates the binding of von Hippel-Lindau E3
ubiquitin ligase complex to ubiquitinate HIF-α and thereby promoting it to proteasomal
degradation [115] (Figure 4). In contrast, under hypoxia, HIF-α accumulates in the cell
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followed by its nuclear translocation to form a transcriptional complex with co-activator
proteins p300 and CBP. The transcriptional complex consists of the dimers HIF-α- HIF1β that binds to the HRE (hypoxia response element) within the promoter of target
genes. The transcribed genes mediate angiogenesis, cell motility, metabolism,
apoptosis, proliferation, and other cellular functions in response to hypoxia [116]. In a
nutshell, under normoxia, HIF-α degradation is regulated via hydroxylation mediated by
the VHL binding, while under hypoxia HIF-α accumulation in the nucleus and its
transcriptional activity is mediated by the binding of p300/CBP to HIF-α [117].
4. Lacrimal gland
4.1. Anatomy and functional role of the lacrimal gland
The lacrimal functional unit (LFU) consists of the lacrimal gland, conjunctiva,
cornea and interconnecting innervations [118]. The aqueous layer of the tear film is
contributed by the lacrimal gland that is essential to maintain a healthy ocular surface,
especially the corneal and conjunctival tissue [99]. The prominent lacrimal gland in mice
and rats is the exorbital lacrimal gland located below the ear which is connected to the
ocular surface by the excretory duct [119]. The main secretory cells in lacrimal gland are
the pyramid-shaped acinar cells that are linked together by tight junctions to form the
racemous glands [99] (Figure 5). The intralobular and interlobular lacrimal ducts consist
of duct cells that help in the modification of the primary products of the lacrimal gland
with water and electrolytes from acinar cell secretions [120]. Another main cell type in
the lacrimal gland is the myoepithelial cell that expresses α smooth muscle actin. These
myoepithelial cells surround the acinar and ductal cells and functions via its contraction
to help excretion of the lacrimal gland fluid [99,120]. Apart from these cell types, the
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existence of immune cells has also been studied, including lymphocytes, dendritic cells,
macrophages, and plasma cells. Under pathological conditions, lymphocyte populations
are reported to increase their population [121]. Intriguingly, the secretion from a lacrimal
gland (tubuloacinar exocrine gland) is tightly regulated by the neural reflex. The
mechanism of neural response occurs via the activation of afferent sensory nerves in
the cornea and conjunctiva that stimulates the efferent nerves (parasympathetic and
sympathetic nerves) innervating the lacrimal gland. The efferent nerve stimulation, in
turn, helps in the release of the neurotransmitters from the nerves innervating lacrimal
glands and promotes secretion from the lacrimal glands onto the ocular surface. The
thin myelinated sensory nerve endings in the ocular surface help in stimulating the
lacrimal gland to secrete the aqueous layer of the tear film [122,123]. These nerves
lose their myelin sheath as they enter the corneal stroma, where they undergo intricate
branching into the subepithelial plexus. Eventually, these nerves branch out further as
thin nerves into the corneal epithelium that ultimately terminates in the apical layers of
the corneal epithelium forming a ‘leash type of nerve endings’ [40]. The sensory nerves
that are present very close to the corneal surface will help in sensing changes in the
tear film due to stress or environmental changes [81]. Therefore, the regulation of
lacrimal gland secretion is controlled by the ‘neural reflex arc’ that involves the
activation of sensory nerves in both cornea and conjunctiva [124]. There are three major
steps involved in the neural regulation of lacrimal gland function; (i) sensory nerve
activation in the cornea and conjunctiva: corneal sensitivity is the prime factor for tear
secretion since sensory nerves play a major role in stimulating tear secretion from the
lacrimal gland. Under conditions such as corneal lesions, microbial keratitis, or epithelial
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defects, reduced corneal sensitivity has been reported to be associated with decreased
tear production [125]. (ii) Efferent parasympathetic and sympathetic nerve stimulation:
neurotransmitters such as acetylcholine and norepinephrine are released upon both
parasympathetic and sympathetic nerve stimulation respectively, to control secretion
from the lacrimal gland. Acetylcholine binds to muscarinic receptors, whereas
norepinephrine binds to an adrenergic receptor to further initiate the signaling pathways
[126]. Despite the presence of efficient afferent neural stimulation, neurotransmitter
release is critical in lacrimal gland secretion. During lacrimal inflammation, a decrease in
tear production is observed due to the blockage of neurotransmitter release and
disabled efferent nerve stimulation [127]. (iii) Signaling pathways in lacrimal gland: in
addition to the neurotransmitter release, signaling pathways activated by its binding to
cognate receptors is also essential in stimulating lacrimal gland secretion. The inhibition
of the signaling pathway was observed when antagonists were bound to muscarinic
receptors and thereby prevents the binding of acetylcholine leading to inefficient efferent
nerve stimulation [121].
In summary, the neural reflex arc is known to involve in ‘cross-talk’ between
ocular surface and lacrimal gland by activating the afferent sensory nerves in the
cornea and conjunctiva that promotes the activation of efferent sympathetic and
parasympathetic nerves. This cascade of events is crucial to signal tear secretion from
lacrimal gland [124].
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5. Conjunctiva
5.1. Anatomy and functional role of the conjunctiva
Conjunctiva is a semitransparent thin mucous membrane that covers the
posterior surface of the eyelids, connects with the eyeball and eventually extends into
the limbus of the cornea. It is highly innervated and vascularized tissue that functions in
protecting the cornea by secreting mucins, antibacterial proteins, water, and electrolytes
which forms both an aqueous and mucous layer of the tear film [128]. Importantly,
conjunctiva plays an essential role in absorbing drugs (permeable to 40KDa) and
actively transports via sodium-dependent, monocarboxylate or dipeptide transporters to
the ocular surface [129,130]. Conjunctiva is anatomically subdivided into three
subdivisions; (1) Tarsal or palpebral conjunctiva lining the eyelids (2) Forniceal
conjunctiva lining the upper and lower fornices (3) Bulbar conjunctiva overlying the
sclera. Conjunctiva consists of the non-keratinizing epithelium with mucin-secreting
goblet cells and eventually becomes continuous with the corneal epithelium [131]
(Figure 6). From a plethora of studies, it is evident that under corneal epithelial cell
damage, limbal stem cells will help in corneal re-epithelization. Interestingly, during
damage to the limbus, development of corneal angiogenesis and migration of goblet
cells in the newly formed corneal epithelium was observed [132]. Rich innervations in
conjunctiva occur via parasympathetic and sympathetic nerves surrounding conjunctival
goblet cells, whereas the sensory nerves innervate the conjunctival epithelial cells
[133,134]. Therefore, corneal sensory nerves will help to promote neural reflex to
stimulate parasympathetic nerves and mucin secretion from conjunctiva [135].
Conjunctival epithelial cells synthesize membrane-bound mucins MUC- 1, -2 -4, -7 and -
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16. MUC-4 is also reported to be secreted as soluble mucin by releasing itself into the
tear film via ‘ectodomain shedding’[128]. Gel-forming mucin, MUC5AC is synthesized
and secreted by the conjunctival goblet cells [136].
Altogether, this study broadens our knowledge on understanding first, an intricate
network of lacrimal gland inflammation during HSV-1 infection in mouse cornea and its
influence on tear secretion, correlating to the maintenance of corneal epithelial integrity
and second, the mechanisms of hypoxia-induced angiogenic mediators in HSV-1
infected mouse cornea. More importantly, this study will also help us to identify novel
strategies for maintaining corneal integrity, to increase and sustain stable tear volume to
alleviate HSK disease severity and thereby control corneal blindness.
6. Insulin-like growth factor binding protein (IGFBPs)
6.1. Insulin growth factor (IGF) and IGFBP-3
Cell survival depends on a balance maintained between the signals that mediate
cell survival and apoptosis. The IGF axis has a unique role to play in managing both
signals. IGF has a prominent role in mediating cell survival factors by binding to IGF-1R
[137]. The IGF system constitutes peptides called Insulin-like growth factors (IGFs),
which are produced in the liver and possess mitogenic activity by interacting with
Insulin-like growth factor receptors (IGFRs). IGFs are of two types that are structurally
similar to insulin, namely IGF-I and IGF-II that are regulated by IGFBPs and IGFBP
proteases [138]. It will be interesting to understand the role of IGFBPs in the regulation
of IGF during corneal HSV-1 infection if any. A 150KDa ternary complex is formed when
IGFBP interacts with the acid -labile subunit (ALS) glycoprotein and the free IGF in
serum. This interaction of IGFBPs and IGF inhibits the binding of IGF to its cognate IGF
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receptor [139]. From the sequencing studies, six different isoforms of IGFBPs have
been identified; IGFBP-1 to IGFBP-6. Among these IGFBP-3 has been reported to be
highly abundant in the serum that can predominantly bind to the free IGF-I/IGF-II in the
serum [140,141]. It has been shown that 1% of the circulating IGF-1 remains in the free
state, while the rest is bound mainly to IGFBP-3 [142]. IGF-1 action can be modulated
by

IGFBP-3 either positively or negatively depending on the tissue, and it’s the

pathologic state [143]. In tumor models, IGFBP-3 has been widely studied to promote
different functions, either apoptosis or support cell survival signals [144]. The binding of
IGFBP-3 to IGF-1 is inhibitory, since it reduces the bioavailability of IGF-1 to promote
mitogenic effects but leads to induce apoptosis. On the contrary, IGFBP-3 binding to
IGF-1 will control IGF-II function positively by slowly releasing the IGF-1 to its binding
receptor IGF-1R. Therefore, IGFBP-3 will help in coordinating the exposure of IGF-1 to
IGF-1R in a well-regulated manner to promote downstream cell survival signaling [137].
The IGF-1R is a transmembrane heterotetrameric protein, which has two extracellular αchains and two membrane-spanning β-chains in a disulfide-linked β-α-α-β configuration
[145,146].
The affinity of IGFBP-3 to IGF-1 reduces when IGFBP-3 is proteolyzed into
fragments and thereby letting the IGF-1 free [147]. Apart from this, IGFBP-3 is also
known to act independently of IGF-1 and functions to promote apoptosis triggered by
p53, TGF-β1/TGF-β2 [148]. IGFBP-3 exists as a cleaved form in specific tissues such
as the vitreous humor of diabetic patients, providing the identification of IGFBP-3
protease [149].In the cornea, IGFBP-3 has been reported to function in myofibroblast
proliferation and differentiation [150]. The membrane-bound expression of IGFBP3 in
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basal and suprabasal cells of central human corneal epithelium were observed in
addition to its increased expression in the surface epithelial cells, thus signifying its role
in cell surface shedding and apoptosis. Prominent expression of IGFBP3 in the basal
cells of peripheral corneal epithelium also indicates its function in the ‘centripetal
migration’ of epithelial cells [151]. IGFBP-3 has also been shown to have a potential role
in apoptosis and anti-growth signaling in the human corneal epithelium [151].In this
study, we will further determine the role of the IGF-1/IGFBP-3 axis in the development
of corneal hem-angiogenesis and HSK disease severity.
6.2. IGF dependent action of IGFBPs
IGF dependent activity of IGFBPs involves sequestration of IGFs. This results in
the rescue of IGF binding to its receptor (IGF-R) [152,153]. A plethora of reports has
reported evidence on the interaction between IGFBPs and IGF [154,155,156]. This
defines the IGF-dependent mechanism of IGFBPs which modulates the bioavailability of
IGF (Figure 7). Binding of IGF molecules to IGF-1R activates intracellular tyrosine
domain of β-chain and causes autophosphorylation at several tyrosine residues in IGF1R [145]. Phosphorylation of tyrosine residues 1131, 1135, and 1136 plays an essential
role in canonical signaling attributed to the receptor [157]. Activated IGF-1R
phosphorylates insulin receptor substrates (IRS-1 and IRS-2) and initiates signaling
cascade. This signaling cascade includes the activation of phosphatidylinositol-3-kinase
(PI3K)/AkT and mitogen-activated protein kinase pathways [158]. IGF-1R signaling has
been well reported to have pleiotropic effects, which includes enhancing cellular
proliferation, migration, neutrophil survival, and effector function, T-cell survival,
promoting hem- and lymphangiogenesis and inhibition of apoptosis [159,160,161].
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The IGF dependent action of IGFBPs was demonstrated by using a recombinant
human mutant of IGFBP-4 that showed a reduced activity to bind IGF-2 molecules. This
reduced binding resulted in the inhibition of osteoblast proliferation [162]. Additionally,
IGF dependent action of IGFBP was also evident from the release of IGF molecules
either by proteolysis of IGFBPs or by alterations in the IGFBP phosphorylation. IGFBP-3
levels in serum have reported being regulated by the protease activity such as plasmin
and serine proteases (Prostate-specific antigen), which degrades IGFBP-3 [154]. Matrix
metalloproteinases (MMPs) are the enzymes known to have proteolytic activity and is
involved in the degradation of IGFBPs. MMPs are the family of Zn 2+- dependent
enzymes that are involved in the remodeling of extracellular matrix components [163].
They are synthesized as proenzyme molecules and become active after removal of an
amino-terminal pro-peptide. MMP-3 and MMP-9 are reported to trigger the proteolysis of
IGFBP-3 resulting in the release of IGF molecules [164,165,166]. Interestingly,
increased IGFBP-3 proteolysis has been reported in pathological conditions such as
cancer and arthritis [167]. Previous studies have shown that MMP-3 and MMP-9 are
involved in the proteolysis of IGFBP-3 in inflamed tissue [168,169]. Interestingly, in the
mouse model of HSK, the expression and activity of MMP-9 have been reported in
HSV-1 infected corneas [170]. While, the reports from our lab showed an increased
level of both, MMP-9 and MMP-3 during the pre-clinical and clinical phase of HSK
(Figure 37). MMP-3 serves as an activator of pro-MMP-9 and helps in the generation of
active MMP-9 [171]. Overall, these studies provide evidence on the proteolysis of
IGFBP-3 in inflamed tissue via MMPs that leads to the release of the bound IGF
molecules.
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6.3. IGF independent action of IGFBPs
IGFBPs can execute its function independent of IGF binding and also by not
influencing IGF receptor signaling (Figure 7). Structurally IGFBP-3 consists of a
conserved N-terminal domain, a mid-region that is highly variable, and a conserved Cterminal domain, with other subdomains and functional motifs which helps in the
functional role of IGFBP-3 [172]. The mid-region of IGFBP-3 essentially plays a role to
promote its interaction with glycosaminoglycans (cell surface proteins) [173]. Recent
reports have suggested the specific binding of IGFBP-3 to cell surface receptor (not the
IGF receptor) in breast cancer cells which mediated growth inhibition in these cells.
Additionally, studies have also reported various types of receptors interacting with
IGFBPs such as type V TGFβ receptor. IGFBP-4, and -5 is known to interact with type V
TGFβ receptor in breast cancer cells [174,175]. Type V TGFβ receptor was found to be
structurally similar to the low-density lipoprotein receptor-related protein-1 (LRP-1)
[176]. The report suggested that binding of IGFBP-3 to Type V TGFβ/ LRP-1 promoted
growth inhibitory signaling in human lung carcinoma cells (H1299) [177]. A recent study
has provided evidence on the involvement of the IGFBP-3 receptor with IGFBP-3
functions in retinal endothelial cells mediating apoptosis [176].
Several reports have demonstrated the IGF independent action of IGFBP-3, and
-5 via its localization to the nucleus [178]. Localization of IGFBP-3 into the nucleus has
been reported due to the presence of a nuclear localization signal (NLS) and the
nuclear transport protein importin-β. Once in the nucleus, IGFBP-3 executes
transcription regulation. IGFBP-3 can also bind to nuclear receptors such as retinoid-xreceptor-α, Vitamin D receptor, peroxisome proliferator-activated receptor-γ (PPAR-γ),
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Nur -77 [179]. Furthermore, the nuclear localization of IGFBPs is also known to promote
the anti-apoptotic effect [180]. IGFBPs also binds to the epidermal growth factor
receptor (EGFR) on the plasma membrane and then translocate into the nucleus in
response to DNA damage and promotes DNA damage repair [181]. IGFBPs may likely
promote cell adhesion and motility in an IGF independent manner. IGFBP-1, and -2 is
known to bind integrin α5β1 (fibronectin receptor) to promote cellular growth signaling
pathway [152]. Moreover, a plethora of reports have indicated the IGF independent
action of IGFBP-3 in mediating cellular growth and angiogenesis in diabetes
[182,183,184]. Taken together, the reports have provided concrete evidence on the
IGF/IGF-R independent action of IGFBP-3 executing either promoting or inhibiting
various cellular processes such as cellular proliferation, growth, and apoptosis.
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Figure 1: Key aspects of Herpes Stromal Keratitis (HSK) development in C57BL/6 mouse
model. The early response to control the virus occurs during the pre-clinical phase. The
actively replicating virus ceases by day 7 post-infection. An influx of inflammatory neutrophils is
detected during the pre-clinical phase. The disease pathology begins to develop during the
clinical phase of the disease (after day 7 post -infection) with the development of hemangiogenesis and corneal opacity. An increased influx of T-cells is detected. Additionally,
another wave of neutrophil influx is also observed at the clinical disease phase. Therefore,
there is a biphasic infiltration of neutrophils during the pathogenesis of HSK disease.
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Figure 2: Structure of Cornea. Layers in cornea showing from the top (anterior)
corneal epithelium layer, Bowman’s layer, corneal stroma, Descemet’s membrane, and
endothelium at the bottom (posterior)
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Figure 3: Layers of tear film. Tear film overlying the corneal epithelium. Membrane
bound mucins on the corneal epithelium function as glycocalyx at the epithelial-tear film
interface. Three layers of tear film from the top (anterior) is the lipid layer, middle
aqueous layer (with soluble mucins), at the bottom (posterior) mucous layer.
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Figure 4: Regulation of Hypoxia Inducible Factor (HIF) pathway in oxygen dependent
manner. In presence of abundant oxygen (normoxia) HIF-1/2α (HIF isoforms) is prone to undergo
proteasomal degradation. This process is initiated by the prolyl hydroxylases (PHD) followed by
the binding of HIF isoforms to von-Hippel-lindau (VHL). However, under low oxygen supply
(hypoxia), stabilization of HIF isoforms occurs upon its translocation to the nucleus.
Heterodimerization of HIF isoforms occur in the nucleus with HIF-1β, along with the cofactor
protein (p300/CBP). This heterocomplex formed in the nucleus promotes the transcription of HIF
target genes that consists of hypoxia response element (HRE) sequences in their promoter
region. (CBP-CREB-Binding protein)
Modified concept from Franke.et.al; Erythrocytosis: the HIF pathway in control; Blood; 2013
122(7):1122-8.
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Figure 5: Histology of Extra-orbital Lacrimal gland from a C57BL/6 mouse. The image is showing the
histology of Extra-orbital lacrimal gland from C57BL/6 mice which was stained with Hematoxylin and
Eosin (H&E). The image shows lobules separated by loose connective tissue (arrows are indicating the
location). Each of these lobules consists of acini (arrows highlighting the acini within the lobules). An
enlarged image of the acinus is shown in the image on the right, indicating acinar cells that are secretory
in function. The lobules also contain ducts (an enlarged image displayed on the right) that helps in
transporting the secreted components from the lacrimal gland.
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Figure 6: Histology of Conjunctiva from a C57BL/6 mouse. The image is showing the histology of
conjunctiva from C57BL/6 mice which were stained with Periodic acid-Schiff (PAS). A. The image shows
the location of the conjunctiva in the cross-section of the Adnexa. B. An enlarged image is showing three
different types of the conjunctiva. The one highlighted in the red is the bulbar conjunctiva or the ocular
conjunctiva (covers the outer surface of the eye), highlighted in blue is the palpebral or the tarsal
conjunctiva (lines the inner side of eyelids), highlighted in green is the fornical conjunctiva (present at the
junction between the bulbar and palpebral conjunctiva). C. An enlarged image showing the goblet cells
(PAS+) lined across the conjunctival epithelium.
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Figure 7: Insulin Like Growth Factor (IGF) dependent and independent action of
Insulin Like Growth Factor Binding Proteins (IGFBPs). In the left panel, showing the
binding of IGF-1 to its receptor IGF-1R. This elicits the signaling cascade upon
phosphorylation of the IGF-1R receptor. While, the presence of IGFBPs modulates the
IGF signaling by its binding to the IGF molecules. This leads to the sequestration of the
IGF molecules and inhibits its binding to the IGF receptor. On the right panel, showing
IGBPs interaction with the cell surface receptors such as LRP-1/type V TGF-β receptor.
Other cell surface receptors yet needs further elucidation. It is known that, IGFBPs upon
its binding with the cognate receptor leads to its internalization inside the cell and gets
transported into the nucleus in an importin-dependent fashion, thereby to promote the
expression of specific genes involved in various cellular process (migration, proliferation,
apoptosis etc).
Modified concept from Wick.et.al; A Darwinian-evolutionary concept of age-related
diseases; Experimental Gerontology 38 (2003) 13–25
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MATERIALS AND METHODS
Mice
Eight- to twelve-week-old C57BL/6 mice were purchased from Jackson
Laboratories (Bar Harbor, ME). This mice strain (stock No 000664) was used for all
experiments mentioned in this study. IGFBP-3-/- mice were provided by Dr.Jena Steinle
laboratory (Wayne State University School of Medicine, Dept of Ophthalmology, Visual
and Anatomical Sciences). The genotype of IGFBP-3-/- mice was confirmed (Figure 8).
All mice were housed at Wayne State University School of Medicine, Division of Animal
Laboratory Animal Resources (DLAR). All experimental animal procedures were
reviewed and approved by the Investigation Animal Care and Use Committee (IACUC)
of Wayne State School of Medicine and the Association for Research in Vision and
Ophthalmology.
Virus
HSV-1 McKrae was obtained from Dr.Daniel J.J. Carr laboratory at the University
of Oklahoma College of Medicine (Oklahoma City, OK). In our laboratory, the virus was
propagated on a monolayer of Vero cells (American Type Cell Culture, Manassas, VA;
CCL81). Infected Vero cells were then pelleted by centrifugation at 3000rpm for 30min
at 4°C. The pellet was resuspended in 2ml PBS and then subjected to three cycles of
flash freeze/thaw in liquid nitrogen and in 37°C water-bath, respectively. The virus was
purified from the supernatant and then titrated to quantify the viral titers using viral
plaque assay. Viral titers were designated as plaque forming units per milliliter (pfu/ml).
Aliquots of the virus were stored in -80°C until used [185].
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Corneal HSV-1 infection
Primary HSV-1 infection in C57BL/6 mice was performed by anesthetizing the
mice

with

an

intraperitoneal

injection

of

ketamine/xylazine

(33mg/kg

body

weight/20mg/kg body weight respectively) in 0.2 ml of 1x phosphate buffered saline
(PBS). Mouse corneas were sacrificed using a 27 ½ gauge needle. 1x105 pfu of HSV-1
McKrae virus was topically applied only to the right cornea in 3ml of 1x PBS. All infected
mice were housed in micro-isolator cages with cage tops and handled in Class II, Type
A2, biosafety cabinet to aid precaution against bacterial superinfection [186].
Clinical Scoring of Herpes Stromal Keratitis (HSK)
Handheld slit lamp biomicroscope (Kowa, Nagoya, Japan) was used to clinically
score each of the HSV-1 infected eyes at day 8, day 10 and day 16 post HSV-1
infection, to determine corneal opacity and development of corneal angiogenesis. A 5point scale is applied to determine the severity of corneal opacity as follows: 0-normal
cornea; 1-mild corneal haze; 1.5- mild corneal haze and with epithelial defect; 2.0moderate opacity with iris visible; 2.5- moderate opacity with iris visible and with
epithelial defect; 3.0- severe opacity with iris not visible; 3.5- severe opacity with iris not
visible and with epithelial defect; 4.0- severe opacity with corneal ulcer; 4.5- severe
opacity with corneal ulcer and with epithelial defect; 5.0- corneal rupture. Corneal hemangiogenesis was determined by measuring the centripetal growth of newly formed
blood vessels in each quadrant of the cornea as follows; A 4-point scale is applied to
determine the length of the blood vessels in each quadrant of the cornea between 0with no angiogenesis and 4-the blood vessels that reach central region of the cornea.
The final score from all four quadrants was summed up to have a total range 0-16 score
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for each eye at a designated time-point. Corneas with an angiogenesis score >4 and
opacity score >2 were scored as severe HSK, whereas the corneas with an opacity
score ≤2 and angiogenesis score ≤4 were scored as mild HSK disease [185,187].
Evaluation of Corneal Smoothness
Stereomicroscope imaging with the LED ring illuminator (Leica Microsystems Inc,
IL, USA) was used to capture mouse eye images on day 4, day 8, and day 10 post
HSV-1 infection to determine corneal smoothness and epithelial defects. The light from
the ring illuminator projects off the corneal surface and the regularity of the circular ring
can be determined depending on the smoothness of the corneal surface. The corneal
smoothness is determined by dividing the projected ring into four quarters, of 3’o clock
position each quarter. Based on a 5-point scale, the severity of corneal irregularity will
be scored depending on the number of distorted quarters as follows: 0-No distortion; 1distortion in one quarter of the ring; 2- distortion in two quarters of the ring; 3- distortion
in three quarters of the ring; 4- distortion in all four quarters of the ring; 5-severe
distortion with no ring formation observed [188,189],
Phenol red thread tear test
This test was used to measure the tear levels in each of the HSV-1 infected
mouse eyes at day -4, -6, -7, -8 and -10 post HSV-1 infection. Each of the unanesthetized mice was held on a stable surface (without touching the facial region or
whiskers) to insert the phenol red (pH indicator) impregnated cotton thread tip (ZQ
1010, ZONE-QUICK, Japan) into the eyes at the lateral canthus region for the 30s
(Figure 9). An eye dressing forceps (Miltex, 18-779) was used to hold the thread.
Appropriate care is taken to avoid touch stimulation to eyelashes and whiskers. The
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change in the thread color from yellow to red was measured in millimeters and
recorded. The thread images with color change were captured immediately [190].
Rose Bengal staining
Rose Bengal staining was used to evaluate the damage to the ocular surface in
HSV-1 infected eyes.1% Rose Bengal (catalog #330000 Sigma Aldrich, MO, USA)
solution was prepared in distilled water. 2µl of the solution was dropped on to the
anesthetized mouse eyes by using a micropipette. After 4 secs, Rose Bengal staining
was washed away from the mouse eyes by using 2µl 1x PBS from the micropipette. The
eye images were acquired by using stereomicroscope. Positively stained areas with
Rose Bengal will appear as magenta/dark pink punctate staining on the ocular surface
[191].
Immunofluorescence staining and confocal microscopy
Immunofluorescence staining was performed on day 4, day 10 and day 12 post
HSV-1 infection and on uninfected (naïve) corneal frozen sections (8µm). Enucleated
eye-globes from naïve, day 4 and day 10 post-infection were transferred into the blocks
with OCT compound (Tissue Tek, CA, USA) that were snap-frozen in liquid nitrogen and
stored at -80ºC. Corneal frozen sections of 8µm were collected on a positively charged
glass slide (Thermofisher Scientific, MA, USA). The samples were air dried for 30min
and later fixed using 2% buffered paraformaldehyde (PFA) for 30min at room
temperature or with acetone (ice-cold) for 10min at -20ºC followed by three washes in
1X PBS for 5min each. Slides were blocked using 3% BSA in 1xPBS with 0.3% Triton
X-100 for 2 hours at room temperature. Slides were then incubated with FITCconjugated mouse monoclonal antibody, raised against the pimonidazole adducts
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formed during hypoxia or with cytoskeletal intermediate filament proteins (K1, K10, K12,
pan-cytokeratin), paired box-6 protein (PAX-6), hypoxia-inducible factor-1α, 2α (HIF-1α,
HIF-2α), glucose transporter-1, 3 (GLUT-1, GLUT-3), monocarboxylate transporter-4
(MCT-4) and Insulin-like growth factor -1 receptor (IGF-1R). The next day, slides were
washed for three times in 1x PBS for 5min each, later incubated for 2hr at RT with
respective secondary antibody (Alexa 488). Slides were rewashed three times in 1X
PBS for 5min each and then mounted with DAPI containing medium (Vector
Laboratories, Burlingame, CA) [186,192]. The sources of antibody and dilution used in
this study are provided in Table 2. Images were acquired in 20x and 40x objective lens
by using Leica True Confocal Scanner SP8 Confocal microscope (Leica Microsystems
Inc, IL, USA).
Corneal whole mount staining and confocal microscopy
Mice were euthanized at day 4 and day 10 post HSV-1 infection to enucleate the
eye globes. The eye-globes were then immediately fixed in 4% PFA for 30min at room
temperature. The corneal tissue was gently dissected (under a dissecting microscope)
separating it from the attaching iris tissue, ciliary body, scleral tissue, and the lens by
using fine curved forceps (Miltex, York, PA). The corneal tissue dissected as a ‘cup
shape’ (Figure 10) was flattened by making six- eight partial cuts from the limbus to the
central cornea and the stored in 30% sucrose using 0.1% EDTA-0.01% hyalurodinase
type IV-S solution at 37ºC for 90min. The tissues were blocked using 3% BSA in 1%
TritonX-100 solution for 90min at room temperature, followed by incubation with primary
antibody (Tuj1) in a humidified chamber for 16hours at 4ºC. The next day, tissues were
washed for four times with 0.3% TritonX-100-PBS solution for 10min each, followed by
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overnight incubation with secondary antibody (Alexa 488) at 4ºC. The next day, tissues
were washed for four times with 0.3% TritonX-100-PBS solution for 10min each and
later mounted with DAPI containing mounting medium (Vector Laboratories,
Burlingame, CA, USA) [190]. The sources of antibody and dilution used in this study are
provided in Table 2. Tile scan Images were acquired using a Leica True Confocal
Scanner SP8 Confocal microscope (Leica Microsystems Inc, IL, USA).
Bromodeoxyuridine (BrdU) incorporation assay
Naïve(uninfected) and HSV-1 infected mice at day 5 and day 9 post HSV-1
infection were given a single dose of intraperitoneal injection (0.2ml/mice) of BrdU
(10mg/ml) in saline solution. Mice were euthanized post 18hrs of BrdU injection, and the
eye-globes were collected to snap- freeze in the OCT compound (Tissue Tek, CA,
USA). Frozen sections of the cornea were collected on a positively charged glass slide
(Thermo Scientific, MA, USA). The sections were let to air-dry overnight at room
temperature and later fixed in 4% buffered para-formaldehyde solution for 15min, later
washed thrice in 1xPBS. For antigen retrieval, sections were immersed in Coplin jar with
2NHCl for 30min at room temperature and subsequently neutralized with 0.1M Borate
buffer (pH 9.0), twice for 5min each. The samples were blocked with 3% BSA in 1xPBS
and incubated at 4ºC with primary antibody for 18hrs (overnight). The next day slides
were washed three times followed by incubation with secondary antibody (Alexa 488)
overnight at 4ºC. The next day, slides were washed and mounted with DAPI mounting
medium (Vector Laboratories, Burlingame, CA, USA) [190]. The sources of antibody and
dilution used in this study are provided in Table 2. Images of 20x and 40x magnification
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were acquired using Leica True Confocal Scanner SP8 Confocal microscope (Leica
Microsystems Inc, IL, USA).
Hematoxylin and Eosin (H/E) and Periodic-Acid-Schiff (PAS) hematoxylin staining
Extra-orbital lacrimal glands (Figure 11) and Adnexa (Figure 12) from the naïve,
day 4 and day 10 post HSV-1 infection were dissected and immediately fixed (in
‘Excalibur’s alcoholic fix solution’). The fixed samples were sent to the core facility
(Excalibur Pathology, OK, USA) to carry out paraffin embedding, sectioning, H/E
staining for Extra-orbital gland tissue samples and PAS staining for conjunctival goblet
cells (from Adnexa tissue sample). Images were acquired by using the Leica light
microscope (Leica Microsystems Inc, IL, USA).
Tissue Processing for Flow cytometry (FACS)
Enucleated eyes from the naïve and infected mice at day -4, -10, -12 and -13
post HSV-1 infection were collected in ice-cold RPMI 1640 medium supplemented with
antibiotics and fetal bovine serum (10%). The corneal tissue was dissected (under a
dissecting microscope) separating it from the attaching iris tissue, ciliary body, scleral
tissue, and the lens by using fine curved forceps (Miltex, York, PA). Each of the cornea
samples was collected in ice-cold RPMI 1640 media + Liberase TL (2.5mg/ml, SigmaAldrich, MO, USA) and placed in a disruptor (1500rpm) at 37ºC for 45min. Each of the
cornea samples was triturated using 3ml syringe plunger and passed through a 70µm
cell strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC)
and then broken down into single cell suspension for FACS staining.
The mouse Extra-orbital lacrimal gland (EoLG) present anterior to the ear, from
the naïve and infected mice at day 4 and day 10 post HSV-1 infection were collected
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(Figure 11) in ice-cold RPMI 1640 media supplemented with antibiotics and fetal bovine
serum (10%). Individual EoLG tissue was minced into 4-5 pieces and then were
collected into RPMI 1640 media + Liberase TL (2.5mg/ml, Sigma-Aldrich, MO, USA).
These samples were placed in a disruptor (1500rpm) at 37ºC for 45min. Each of the
EoLG samples was triturated using 3ml syringe plunger and passed through a 70µm
cell strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC)
and then broken down into single cell suspension for FACS staining.
Conjunctival tissue (pooled- right and left eyes) from the naïve and infected mice
at day 4 and day 10 post HSV-1 infection were dissected from the Adnexa (Figure 12)
by using a surgical blade #11. Under the dissection microscope, loosely attached
conjunctival tissue (includes palpebral, whole bulbar and forniceal conjunctiva) was
separated from the sclera and eyelids by corneal scissors. The pooled conjunctival
tissue was collected into RPMI 1640 media + Liberase TL (2.5mg/ml, Sigma-Aldrich,
MO, USA). The samples were placed in a disruptor (1500rpm) at 37ºC for 40min,
followed by trituration using 3ml syringe plunger and was passed through a 70µm cell
strainer. The samples were pelleted by centrifugation at 1000rpm for 10min (4ºC) and
then broken down into single cell suspension for FACS staining.
Spleen samples from the naïve and infected mice were collected in ice-cold
RPMI 1640 media supplemented with fetal bovine serum (10%) and antibiotics.
Individual spleen tissues were triturated by using 3ml syringe plunger and was passed
through a 70µm cell strainer. Red Blood Cells (RBCs) were lysed by using RBC lysis
buffer (Sigma-Aldrich, MO, USA). The spleen cells were counted by using
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hemocytometer (to plate 106 cells/well in 96 well plates for cell surface flow cytometry
staining).
Flow Cytometry cell surface staining
Cell surface staining was carried out on single cell suspension processed from
the tissue samples. Individual samples were plated in the 96 well u-bottom plates. Cells
were washed with FACS buffer (PBS+FBS+0.1%sodium azide) followed by blocking of
Fc receptors (CD16/32 antibody) on ice for 30min. Next, the individual samples were
stained with fluorochrome-conjugated antibodies. The sources of antibody and dilution
used in this study are provided in Table 1. Samples were fixed overnight with 1:1 2%
PFA: FACS buffer and acquired the next day on LSR Fortessa flow cytometer. The data
were analyzed using FlowJo software.
Flow Cytometry intracellular staining
Intracellular staining was carried out on single cell suspension processed from
the tissue samples. Individual samples were plated in 96 well u-bottom plates. Cell
surface staining on individual samples was carried out after blocking with Fc block
(CD16/32 antibody) on ice for 30min. The BD Biosciences cell membrane
permeabilizing staining buffer set (Cytofix/Cytoperm 554714, BD Biosciences, CA, USA)
was used for intracellular pimonidazole and IGF-1R staining. The eBioscience
transcription factor staining buffer set (005523-00, Thermofisher Scientific, MA, USA)
was used for HIF-1α staining. The staining buffer set was used as per the
manufacturer’s protocol. The sources of antibody and dilution used in this study are
provided in Table 1. Samples were fixed overnight with 1:1 2% PFA: FACS buffer and
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acquired the next day on LSR Fortessa flow cytometer. The data were analyzed using
FlowJo software.
RNA isolation, Quantitative Reverse Transcriptase Polymerase Chain Reaction
(qRT-PCR), Hypoxia Signaling Pathway RT2 profiler PCR array
Individual cornea samples dissected from naïve, day 5 and day 10 post HSV-1
infection were collected into RNeasy lysis buffer (RNeasy micro kit; QIAGEN, MD, USA)
and homogenized using a Qiagen Tissue Lyser (Qiagen, MD, USA). The total RNA was
extracted, as per the manufacturer’s protocol (RNeasy micro kit; QIAGEN, MD, USA).
Quantification

of

purified

RNA

was

carried

out

using

NanoDrop

ND-1000

spectrophotometer (Thermofisher Scientific, MA, USA). One microgram RNA was
reverse transcribed using RT2 First Strand Kit (QIAGEN, MD, USA) to prepare cDNA for
the qRT-PCR assay. The optimal cycling conditions required to run the qRT-PCR assay
were set, starting with the hot start cycle for 10min at 95ºC, followed by the PCR
amplification for 15s at 95ºC and 60s at 60ºC with cycle repeated 40 times. The 96-well
Hypoxia Signaling Pathway RT2 Profiler PCR Array (Qiagen, MD, USA) was carried out
as per the manufacturer’s protocol. The qRT-PCR assay was carried out using the CFX
Connect Real-Time PCR Detection System (Bio-Rad, CA, USA). qRT-PCR Primers
used in this study are provided in Table 2. The data obtained from the qRT-PCR assay
was calculated as fold differences in gene expression after normalization with β-actin
(housekeeping gene). The results were represented as relative gene expression by
using the 2-ΔΔCT method of calculation [ΔΔ cycle threshold (CT) = ΔCT (experiment)ΔCT (control)].
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Lactate colorimetric assay
L (+) Lactate concentration from the naïve (uninfected) and day 10 post HSV-1
infection corneal lysates were measured by the lactate colorimetric assay kit (MAK064,
Sigma Aldrich) as per the manufacturer’s protocol. Briefly, each of the corneal samples
was collected in 150μl of lactate assay buffer. The samples were homogenized using
handheld homogenizers (Random # 440613) and centrifuged at 13,000 x g for 10min at
4°C to remove insoluble material. The supernatant was passed through 10KDa spin
columns (ab93349, Abcam) to deproteinize and remove the remaining lactate
dehydrogenase in the sample. The Elute collected from the columns (50μl) is used to
prepare a master mix containing 50μl of the reaction mixture (2µl enzyme mix, 2µl
lactate probe and 46µl of assay buffer). The prepared reaction mixture was then
incubated at room temperature for 30min. Lactate standards were prepared by diluting
100nmole/µl lactate to 1nmole/µl standard solution. Volumes of 0,2,4,6,8 and 10µl of
1nmole/µl lactate standard were used to generate the lactate standard curve. Sample
absorbance was measured using a colorimetric microplate reader (Molecular devices,
spectra max plus, NH, USA) at 570nm (A570). The results were represented as
nanograms per microliter (ng/µl).
Viral Titration assay
HSV-1 virus load in infected Extra-orbital lacrimal glands (EoLG) at day 5 and
day 10 post HSV-1 infection were determined by collecting the tissues in 500µl serumfree DMEM media and then stored in -80ºC until used. Quantification of infectious virus
was enumerated using a standard viral plaque assay. Vero cells (CCL81, American
Type Cell Culture, Manassas, VA;) were grown in a 12-well plate (0.2x106 cells/well).
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The EoLG samples to be tested for viral load were thawed on ice and homogenized
using the hand-held homogenizer (Random # 440613). The EoLG samples were
appropriately diluted in DMEM serum free media and added to each of the wells
containing confluently grown Vero cells. The 12 -well culture plates were incubated at
37º C/5% CO2 for 60min. Samples were removed carefully and replaced by 1ml of
minimal essential media/carboxymethyl cellulose overlay media. Plates were incubated
37º C/5% CO2 for 48hrs to allow the plaque formation. The overlay media was later
removed gently to avoid any loss of cell sheet and replaced by 1ml of glutaraldehyde
fixative (50x diluted in 1xPBS) for 5min at room temperature. After removing the fixative,
cells were then stained with Coomassie blue for 1hr at 37ºC. Plaques were counted
under a bright light source to enumerate the number of plaques forming units (PFU) per
EoLG.
Mouse angiogenesis protein array analysis
An array of angiogenesis-related proteins was measured in HSV-1 infected
corneal samples from B6 and IGFBP-3-/- mice in naïve and at day 5, day 10 and day 15
post HSV-1 infection by using Proteome Profiler Mouse Angiogenesis Array kit
(ARY015, R&D systems, MN, USA). Cornea s dissected from the naïve and infected
groups from B6 and IGFBP-3-/- mice were transferred to 1XPBS with protease inhibitor
cocktail (Sigma Aldrich, MO, USA) and were stored at -80ºC. The cornea samples were
sonicated at 50% amplitude with a cycle of 15s-pulse, followed by resting on ice for
1min. A total of six cycles of sonication per cornea was performed. The sonicated
samples were later centrifuged at 4ºC at 15,000 rpm for 10min. The supernatant was
collected to estimate the protein concentration in each sample by using the BCA protein
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assay kit (Thermo Scientific, MA, USA). Samples were pooled to obtain a minimum of
200µg of protein for angiogenesis array analysis as per the manufacturer’s instructions.
Positive signals on the membrane were quantified using Image Studio Lite Version 4.0.
Enzyme-linked immunosorbent assay (ELISA) to determine the amount of Insulinlike growth factor binding protein-3 (IGFBP-3) and Insulin-like growth factor-1
(IGF-1)
To quantitate the amount of IGFBP-3 and IGF-1 in the corneas of B6 mice,
individual cornea sample was collected in 1XPBS with protease inhibitor cocktail (Sigma
Aldrich, MO, USA) and stored at -80ºC. Individual samples were sonicated at 50%
amplitude with a cycle of 15s-pulse, followed by resting on ice for 1min. A total of six
cycles of sonication per cornea was performed. The sonicated samples were later
centrifuged at 4ºC at 15,000 rpm for 10min. The supernatant was collected for the assay
using mouse IGFBP-3 Duo set (DY775, R&D systems, MN, USA) and mouse IGF-1
ELISA (22-IGF1MS-E01, ALPCO, NH, USA) and followed as per manufacturer’s
instructions. Sample absorbance was measured using a colorimetric microplate reader
(Molecular devices, spectra max plus, NH, USA).
Intraperitoneal (i.p.) injection of Hypoxyprobe-1 (Pimonidazole) to detect hypoxia
Hypoxyprobe-1(HP1-100 kit; Hypoxyprobe-1 kit, Pimonidazole Hydrochloride,
Natural Pharmacia International Inc, MA, USA) i.p. Injection (1.2mg/20g body weight)
was given to the naïve (uninfected) mice and at day 4, day 10 and day 15 post-infection.
The drug was dissolved in 0.9% normal saline. Mice were euthanized ninety minutes
after injection, to collect the enucleated eye-globes. The Individual eye-globe was
submerged immediately into the blocks containing the OCT compound (Tissue- Tek,
CA, USA) and was snap-frozen into liquid nitrogen. The OCT blocks were stored in -
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80ºC until used for sectioning and immunofluorescence staining with the anti-PIMO
antibody. The source of antibody and dilution used is provided in Table 1.
Quantification of Hypoxyprobe-1 (Pimonidazole) staining
Immunofluorescence images stained with anti-PIMO antibody were quantified by
measuring the area of interest showing positive staining. This was acquired by using the
‘Threshold’ tool on a grayscale image by using the Image J software (1.4q version, open
source software) and by setting the measurements to analyze ‘limit to threshold’ so that
the ‘Area of fraction’ in the image is only limited to the threshold region that will be
highlighted. Each section is set to the threshold at different areas of positively stained
areas and was performed at least three times. The quantification of pimonidazole
positively stained area was represented as the percentage of pimonidazole positively
stained areas that depicts the percentage of pixels selected, by using the threshold tool
as described previously [193,194,195].
In-vivo depletion of neutrophils by administration of anti-Ly6G (IA8) antibody
Intraperitoneal (i.p.) injection of anti-Ly6G (clone IA8; BE0075-1, Bio X Cell)
monoclonal antibody (mAb) was given to the HSV-1 infected mice at the dose of
500µg/day/mouse- as the first injection dose. Subsequent injections were given at the
dose of 250µg/day/mouse to the treated group of mice. The isotype-matched antibody
was administered to a control group of infected mice. Anti-Ly6G mAb antibody injections
were given to deplete neutrophils starting from day 7 to day 11 post HSV-1 infection for
a total of five injections. On day 12 post-infection, mice from both the groups were given
i.p. Injection of hypoxyprobe-1 (pimonidazole) and were euthanized ninety minutes later
to collect corneas and spleen tissue. By flow cytometry, individual corneal samples were
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analyzed to determine the extent of pimonidazole staining in the different subsets of
immune cells. To confirm the in-vivo depletion of neutrophils, individual spleen samples
were analyzed to enumerate the frequency of neutrophils (Gr1high).
Intraperitoneal (i.p.) injection of the Acriflavine (ACF) for inhibition of hypoxiainducible factor-1α, 2α (HIF-1α and HIF-2α)
i.p. Injection of ACF (A8126, Sigma Aldrich, MO, USA) was given to the HSV-1
infected group of mice, and i.p. Injection of vehicle (PBS only) to the control group of
HSV-1 infected mice. ACF i.p injection of 8mg/kg body weight in PBS- 0.2ml per mice
were given twice a day, from day 6 to day 9 post HSV-1 infection or from day 6 to day
11 post HSV-1 infection, for a total of 8 or 12 injections respectively. Corneal opacity
and corneal hem-angiogenesis scores were determined in the infected corneas from
both groups of mice by using a hand-held slit lamp microscope as described earlier in
this section. Flow cytometry analysis of individual cornea samples from both the groups
was performed to enumerate the frequency of immune cell subsets at day 12 postocular infection.
Topical administration of Lacritin to increase tear production in HSV-1 infected
C57BL/6 mouse eyes
Topical administration of lacritin (product received from Dr. Robert L. Mc Kown,
Dr. Gordon W. Laurie) was given to the HSV-1 infected group of mice, four times a day
at a dose of 4µM. Control group of HSV-1 infected mice received four times a day C-25
(a lacritin truncation mutant). The treatment was given from day 4 through day 10 post
HSV-1 infection. Tear levels were measured in both the treated and control group of
mice at day 6, 8 and 10 post-ocular infections. Corneal opacity and corneal hemangiogenesis scores were determined in the infected corneas from both groups of mice
by using a hand-held slit lamp microscope as described earlier in this section. Flow
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cytometry analysis of individual extra-orbital lacrimal glands from both the groups was
performed to detect the influx of immune cells (CD4+ CD45+) at day 10 post-ocular
infection.
Statistical Analysis
Statistical analysis was carried out by using the GraphPad Prism software (San
Diego, CA). Each of the experiments was repeated at least two times. The minimum
number of mice used in all experiments were five (n=5). Significance (p values) in all
experiments were calculated by using an unpaired two-tailed parametric t-test or nonparametric Mann- Whitney U test. Statistical analysis in two independent groups was
performed by using One-way ANOVA.
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Figure 8: Protein Array blot is showing no IGFBP-3 expression to confirm the knock out
-/-

phenotype in IGFBP-3 mice. A. An Image of the protein array blot showing IGFBP-3 protein in the
C57BL/6 mice, while no expression of IGFBP-3 was detected in the IGFBP-3-/- mice.
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Figure 9: Phenol Red Thread Test in C57BL/6 mouse eyes. Image showing inserting
of the cotton thread impregnated with phenol red (ZONE-QUCIK, Japan) into the lateral
canthus of C57BL/6 mouse eyes by using the forceps. The phenol red upon contact
with tears will change its color from yellow to red.
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Figure 10: Dissection of Clean Cornea from C57BL/6 mouse eyes. A. Showing image of
dissected whole eye globe placed in ice cold sterile RPMI supplemented media with 10% FBS. B.
Showing image of dissected clean corneal cup. Dissection was performed by removing out the lens,
attached iris, and ciliary process. Curved corneal scissors (Miltex, York, PA) was used for this
dissection.
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Figure 11: Dissection of Extra-orbital lacrimal gland from C57BL/6 mouse. Image of Extraorbital gland location in the temporal area. The circled area in the image showing the surgical
area with the extra-orbital lacrimal gland (EoLG) located with the ducts (lacrimal ducts)
branching off from the glands. Enlarged image of the dissected EoLG is shown in the inset.
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Figure 12: Dissection of Adnexa from a C57BL/6 mouse. A. Showing dissected Adnexa with a whole
eye globe and eyelid. B. Displaying an enlarged image of the Adnexa. Dissected Adnexa is used to
further dissect the bulbar conjunctiva for FACS staining, or the whole adnexa is fixed for histology
preparation.
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Antibody
HIF-1 alpha
HIF-2 alpha

Clone
Monoclonal
Polyclonal

Fluorochrome
Alexa 647
Unconjugated

Dilution
1:20
1:100

Catalog #
R&D systems, IC1935R
Novus, NB100-122

GLUT-1

EPR3915
Monoclonal
Polyclonal
Polyclonal

Alexa 488

1:50

Abcam, ab195359

GLUT-3
MCT-4
(SLC16A3)
Hypoxyprobe-1 Monoclonal
(Pimonidazole)
Donkey antiPolyclonal
Rabbit
Isotype Control Monoclonal

FITC
Un-conjugated

1:200
1:100

Abcam, ab136180
Novus, NBP1-81251

FITC

1:100

Hypoxyprobe, FITC-Mab

Alexa 488

1:200

Alexa 647

1:20

Molecular Probes
A21206
R & D systems, IC002R

CD4

RM4-5

BV605

1:100

BD Biosciences, 563151

CD11b

M1/70

PerCp-Cy5.5

1:100

BD Biosciences, 550993

CD45

30F-11

PE-Cy7

1:100

BD Biosciences, 552848

Ly6G

1A8

Alexa 700

1:100

BD Biosciences, 561236

Tuj1

1-15-79
Monoclonal

Un-conjugated

1:100

BrdU

BU1/75
Monoclonal
EP1607-IHCY
Monoclonal

Un-conjugated

1:100

Covance, MRB-435P-100
(now available from
Biolegend)
Abcam, ab6326

Unconjugated

1:200

Abcam, ab76318

K12

SC-17101/L-15
Polyclonal

Un-conjugated

1:100

K1

EPR17870
Monoclonal

Unconjugated

1:200

Santa Cruz
Biotechnologies,
sc-17101
Abcam, ab185629

PAX-6

Poly19013

Un-conjugated

1:150

Biolegend, PRB-278P

IGF-1R

(pY1131)
K74-218

Alexa 647

1:10

BD Biosciences, 558588

K10

Table1: List of Antibodies used for Immunofluorescence and Flow cytometry
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Catalog #

Gene Symbol

Description

Ref Seq Accession #

PPM03503F
PPM36694A
PPM05505C

Hk2
Pfkp
Pfkfb3

Hexokinase 2
Phosphofructokinase, platelet
6-Phosphofructo-2kinase/fructose-2, 6biphosphatase 3

NM_013820.3
NM_019703.4
NM_133232.3

PPM04168A

Slc2a1

NM_011400.3

PPM04164A

Slc2a3

PPM27328A

Slc16a3

Solute carrier family 2
(facilitated glucose transporter),
member 1
Solute carrier family 2
(facilitated glucose transporter),
member 3
Solute carrier family 16
(monocarboxylic acid
transporters), member 3

PPM28207F

Pdk1

NM_172665.5

PPM29621B
PPM34700A

Cs
Idh2

PPM05102A

G6pdx

PPM82289A
PPM35183A

Pgls
Pgd

Pyruvate dehydrogenase
kinase, isoenzyme 1
Citrate synthase
Isocitrate dehydrogenase
2(NADP)+, mitochondrial
Glucose-6-Phosphate
dehydrogenase X-linked
6-Phosphogluconolactonase
Phosphogluconate
dehydrogenase

NM_011401.4
NM_030696.3

NM_026444.3
NM_173011.2
NM_008062.2
NM_001294269.1
NM_001081274.1

Table2: List of Qiagen Primers used for qRT-PCR assay
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CHAPTER 1: DEVELOPMENT OF INFLAMMATORY HYPOXIA AND
PREVALENCE OF GLYCOLYTIC METABOLISM IN PROGRESSING
HERPES STROMAL KERATITIS LESIONS
Abstract
Herpes Stromal keratitis (HSK) is a chronic immuno-inflammatory condition in
cornea caused by recurrent herpes simplex virus-1 (HSV-1) infection. One of the wellknown causes of the development of hypoxia is chronic inflammation. Here, our study
was focused on understanding the three key aspects of hypoxia, namely, (i)
development of hypoxia in HSV-1 infected mouse cornea, (ii) identification of hypoxiaassociated glycolytic gene expression in HSV-1 infected mouse cornea, and (iii) the
results of blocking hypoxia-inducible factor (HIF) dimerization on the pathogenesis of
HSK. The results from this study showed the development of hypoxia associated with
an increased level of glycolytic gene expression, an elevated level of lactate
concentration and an increased level of neutrophils influx during clinical disease onset
of HSK. However, in-vivo administration of anti-Ly6G antibody not only depleted
neutrophils but also reduced the development of hypoxia that was detected by antipimonidazole staining in the HSV-1 infected corneas. Nuclear stabilization of HIF-1α
and HIF-2α was observed in the infiltrating immune cells and corneal epithelium
respectively, in the HSV-1 infected cornea. Intriguingly, in-vivo administration of
acriflavine inhibited nuclear stabilization of both, HIF-1α and HIF-2α during clinical
disease onset of HSK.
Additionally, acriflavine treatment also resulted in the reduced corneal hemangiogenesis with yet, an increased corneal opacity in HSV-1 infected corneas. The
Immune cell influx upon acriflavine treatment increased neutrophil influx and in contrast,
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a decrease in an influx of CD4 T cells and non-granulocytic myeloid cells. Overall, this
study sheds light into the key factors involved in the development of inflammatory
hypoxia and the expression of hypoxia-associated genes during the disease
progression of HSK.
Introduction
Hypoxia is the most common phenomenon that occurs in tissues with
inflammation [197]. The major event that occurs during hypoxia is the nuclear
stabilization of HIF. The transcription factor, HIF remains inactive during abundant
oxygen supply in the cells but gets activated in hypoxic conditions (depleted oxygen
supply in the cells) [197]. The HIF isoforms, namely, HIF-1α and the HIF-2α. The
isoforms get complexed as a heterodimer with the constitutively expressed isoform,
HIF-1β [197]. The heterodimer translocates into the nucleus and promotes the
transcription of a battery of genes that play a role in cell survival, cell differentiation,
angiogenesis, and glucose metabolism [198,199].
HSK is a chronic inflammatory condition that develops in response to HSV-1
infection in the cornea. As described earlier, HSK in a mouse model is broadly classified
into pre-clinical and clinical disease phase [29]. During the pre-clinical disease phase,
infiltrating innate immune cells with inflammatory monocytes and the NK cells and the
type 1 interferon signaling events are involved in the process of viral replication
[200,201]. However, viral clearance occurs at 6-day post-infection. During the clinical
disease phase, the influx of leukocytes occurs, especially the T-cells in the corneal
stroma. The neutrophil influx has been studied as the most prominent innate immune
cell type during both, the pre-clinical and the clinical disease phase of HSK [30,202].
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Development of corneal hem- and lymph-angiogenesis, opacity and scarring that affects
the clear vision and visual acuity are the consequences of the increased neutrophil
influx in HSV-1 infected cornea [203,204]. It has been previously studied that the influx
of neutrophils into mucosal tissue can re-model the development of inflammatory
hypoxia [205,206]. Therefore, the focus of the current study was to investigate the
development of hypoxia and hypoxia-associated gene expression during the
progression of HSK disease.
Results
Development of inflammatory hypoxia in HSV-1 infected cornea
HSV-1 infected corneas with inflamed lesions are known to become hypoxic
[206,197]. During the clinical onset of HSK disease at day 7 post-infection, a massive
influx of neutrophils is observed in the mouse model with HSV-1 infection in cornea
[202]. To investigate the development of hypoxia, a chemical hypoxia marker namely,
pimonidazole

(2-nitroimidazole)

was

used

to

detect

hypoxic

regions

in-vivo.

Pimonidazole undergoes a cascade of chemical reactions and gets reductively activated
in cells with hypoxia. Pimonidazole forms stable adducts by binding to the thiol groups
in amino acids, peptides, and proteins [194,207]. These adducts can be imaged in-vivo
by staining the tissue sample with FITC conjugated anti-pimo antibody. Notably,
pimonidazole is not active within apoptotic and necrotic regions but specifically indicates
hypoxic regions in the tissue [207]. HSV-1 infected mice were injected with
pimonidazole drug intraperitoneally (i.p.) both at pre-clinical (day 4 post-infection) and at
clinical disease phase of HSK (day 10 and 15 post-infection) as described in Materials
and Methods. Our results showed faint staining of pimonidazole at day 4 post-infection
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in contrast to an intense pimonidazole staining at day -10, and -15 post-infection in
HSV-1 infected cornea (Figure 13 A). The controls used for pimonidazole staining were
the naïve (uninfected control), day 10 post infected cornea with no pimonidazole drug
injection and, the isotype control. As expected, all the controls showed no positive
staining of pimonidazole. Next, we showed a progressive increase in the influx of the
neutrophils in HSV-1 infected corneas at the clinical disease onset of HSK (Figure 13
B). Interestingly, these results correlated with the magnitude of the pimonidazole
staining. Additionally, quantification of pimonidazole staining was carried out that
showed a significant increase in the pimonidazole stained hypoxic regions in the severe
HSK compared to the mild HSK diseased corneas (Figure 13 C).
Furthermore, to determine the contribution of neutrophils influx to the
development of hypoxia in HSV-1 infected cornea, the depletion of neutrophils was
carried out using the anti-Ly6G (IA8 clone) monoclonal antibody (mAb). The HSV-1
infected mice were injected i.p. with anti-Ly6G mAb from day 7 through day 11 postinfection as described in materials and methods. Our results confirmed the depletion of
neutrophils by detecting the reduced frequency of Gr1 high cells (Figure 14 A) in the
spleen of HSV-1 infected mice at day 12 post-infection. In correlation to the depletion of
neutrophils, a significant decrease in the magnitude of the pimonidazole staining was
observed in HSV-1 infected corneas (Figure 14 B). Recent reports have demonstrated
the pimonidazole staining and its quantification on immune cells by using flow cytometry
[208]. In our study, HSV-1 infected corneas, from the mice treated with anti-Ly6G mAb
showed a significant decrease in the pimonidazole staining on non-leukocytes and
granulocytes by using flow cytometry. On the other hand, no significant decrease in
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pimonidazole staining was noted on the CD4 T cells (Figure 14 C). Overall our results
corroborate the involvement of neutrophil influx to be the cause for the development of
hypoxia in HSV-1 infected corneas with progressing HSK lesions.
Increased mRNA levels of hypoxia-associated genes in HSK developing corneas
Recent reports have indicated the importance of hypoxia in altering the gene
expression profile, such as regulating cellular metabolism in the inflamed tissue [199].
Therefore, we hypothesized that the development of hypoxia in HSV-1 infected cornea
is not a bystander event. The genes involved in hypoxia-associated signaling was
detected was using the Hypoxia Signaling Pathway RT 2 Profiler PCR Array on naïve,
day-5, -10 post-infection cornea samples. Increased expression of genes encoding
lactate transporter, glucose transporters, and glycolytic enzymes were detected in HSV1 infected corneas at day-10 post-infection (Figure 15). The qRT-PCR assay was
performed to corroborate the results obtained from the PCR array. Our data showed a
significant increase in the mRNA levels of the enzymes involved in glycolysis namely,
Hk2 (Hexokinase-2), Pfkp (phosphofructokinase platelet), Pfkfb3 (6-phosphofructo-2kinase/fructose-2,6-biphosphatase 3) with an average of 3.49, 6.06 and, 7.1-fold
increase respectively (Figure 16 A). Additionally, an increase in mRNA levels of glucose
transporters namely, Slc2a1(Glut-1; 4.0-fold increase), Slc2a3 (Glut-3; 33.25-fold
increase) and, Slc16a3 (Mct-4; 22.5-fold increase) was determined in HSV-1 infected
corneas at day 10 post-infection with progressing HSK lesions (Figure 16 B). Apart from
glycolysis, mRNA levels of genes contributing the other oxygen-dependent metabolic
pathways were explored such as the Pentose Phosphate Pathway (PPP), and
Tricarboxylic Acid Cycle (TCA) in HSV-1 infected corneas.
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Interestingly, our results showed no significant increase in the genes involved in
the mRNA levels of genes involved in regulating the oxidative phase of PPP namely,
G6pd (glucose-6-phosphate dehydrogenase), Pgls (6-phosphogluconolactonase), Pgd
(phosphogluconate dehydrogenase) (Figure 16 D). However, a decrease in the mRNA
level of a gene involved in the TCA cycle namely, Pdk1 (pyruvate dehydrogenase
kinase-1; an average of 40% decrease) was determined (Figure 16 C).

PDK1

phosphorylation of PDH enzyme leads to deactivation of the enzyme activity in
converting pyruvate to acetyl CoA. The acetyl CoA entering the TCA cycle is then
converted to citrate by citrate synthase. Therefore, from our results, we further
hypothesized that a decrease in the mRNA levels of Pdk1 would likely influence
increased enzyme activity of PDH in HSV-1 infected corneas. Intriguingly, our results
showed a significant increase in the mRNA levels of Idh2 (isocitrate dehydrogenase-2,
mitochondrial), with an average of 25% reduction in Cs (citrate synthase) in HSK
developing corneas compared to the control (naïve corneas) (Figure 16 C). Altogether,
the results obtained from the gene expression profile suggests that glycolysis is not the
exclusive metabolic pathway, but also TCA cycle may likely play a trivial role in HSV-1
infected corneas during the clinical onset of the HSK disease.
As aforementioned, our results showed a dramatic increase in the mRNA levels
of glucose transporters (Glut-1, Glut-3) and the lactate transporter (Mct-4) in HSV-1
infected corneas (Figure 16 B). We were further interested in studying the localization
pattern in the frozen sections of the naïve and HSV-1 infected corneas (day-10 post
infection) by employing immunofluorescence and confocal imaging. GLUTs and MCTs
are the cell membrane-associated proteins with its prime function being glucose import
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and lactate export respectively [209,210]. Our results showed a faint membrane staining
of GLUT-1 only in the basal layer of the naïve corneal epithelium, while in day 10 postinfection cornea intense staining of GLUT-1 was observed in the basal and wing cell
layer of the corneal epithelium (Figure 17 A). Surprisingly, GLUT-1 staining was not
observed in the corneal stroma, which was massively infiltrated with neutrophils and
CD4 T cells during HSV-1 infection.
On the other hand, GLUT-3 staining was very clearly observed in the corneal
stroma (Figure 17 A), indicating its importance as an essential glucose transporter in the
corneal stromal cells of HSV-1 infected cornea. Our results as shown previously (Figure
16 B), a significant increase in the mRNA levels of MCT-4 was observed (average of
33.25±9.82-fold increase) in HSV-1 infected cornea. In support with this, MCT-4 also
showed an intense membrane staining in the epithelial and stromal layer of the cornea
(Figure 17 A). Additionally, flow cytometry results also showed a significant increase in
the expression of MCT-4 protein on the neutrophils than the CD4 T cells in HSV-1
infected corneas (Figure 17 B). MCT-4 isoform is well known to execute lactate export
and is reported to be highly expressed in hypoxic tissues with increased glycolysis.
Lactate is the metabolic end-product of glycolysis that is exported or imported by
various isoforms of MCTs [210,209]. Therefore, understanding the importance of MCT-4
in exporting the intracellular lactate, we determined the lactate levels in the naïve vs.
HSV-1 infected corneas (Figure 17 C). Our data showed high levels of L-lactate in day
10- post-infection corneas compared to the uninfected corneas. Altogether, our data
support the prevalence of glycolytic metabolism in HSV-1 infected corneas with
progressing HSK lesions.
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Stabilization of HIF-1α and HIF-2α in HSV-1 infected corneas
Nuclear localization of the HIF isoforms (HIF-1α and HIF-2α) is the hallmark of
hypoxia [211]. Therefore, we ascertained the nuclear localization of HIF-1α and HIF-2α
in HSV-1 infected corneas by employing confocal imaging and flow cytometry
respectively. Nuclear localization of HIF-2α was distinct in the corneal epithelium of the
infected corneas at day 10 post-infection (Figure 18). On the contrary, no nuclear
localization of HIF-2α was observed in the naïve or the corneas at day 4 post-infection
(Figure 18).
HIF-1α is well known to regulate the immune cell function [212,213,214]. During
the clinical onset of HSK disease, corneal stroma is heavily infiltrated with CD4 T cells
and neutrophils. Hence, we carried out intracellular flow cytometry analysis (as
described in materials and methods) to determine the HIF-1α stabilization in infiltrating
immune cells in HSV-1 infected corneas. Our data showed increased HIF-1α expression
in the leukocytes than the non-leukocytes in the HSV-1 infected corneas during the
clinical disease period (Figure 19 B). Interestingly, differential levels of HIF-1α nuclear
localization were detected in the order of myeloid cells > CD4 T cells > neutrophils
(Figure 19 B). Naïve B6 corneas only showed minimal levels of HIF-1α in the resident
leukocytic cell populations (Figure 19 A). Overall, these results demonstrated the
nuclear colocalization of HIF-1α/ HIF-2α showing a pattern of differential levels of its
expression in specific cell types in HSV-1 infected cornea during the clinical disease
period.
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Acriflavine treatment aggravated corneal opacity, but reduced hem-angiogenesis
in HSV-1 infected cornea
As aforementioned, our results demonstrated the stabilization of HIF-1α and HIF2α in immune cells and corneal epithelium respectively, in HSV-1 infected corneas.
Therefore, we selected the Acriflavine (ACF) drug to inhibit HIF signaling via direct
binding to the PAS domain of HIF-1α and HIF-2α. This results in the blocking of HIF
dimerization with HIF-1β causing inhibition of HIF transcription activity [215]. Systemic
administration of ACF was given to HSV-1 infected mice as described in materials and
methods. The effect of the drug treatment was determined by scoring corneal opacity
and corneal angiogenesis in both the control and treated group at day 10 post-infection.
Unexpectedly, our results showed a significant increase in the corneal opacity scores
(Figure 20 A), while a significant decrease in angiogenesis scores was observed in the
ACF treated group of HSV-1 infected mice (Figure 20 C). Additionally, an increased
incidence of eyes with an opacity score of ≥3.0 was observed in ACF treated a group of
mice (Figure 20 B). In ACF treated group of mice, a significant decrease in the mRNA
levels of Pfkfb3 was observed in the infected corneas compared to the vehicle-treated
group of HSV-1 infected mice (Figure 20 D). Intriguingly, our results showed a
significant decrease in the mRNA levels of Pfkfb3 in correlation to a significant decrease
in angiogenesis scores in the ACF treated group of infected mice. In conclusion, our
data suggested that ACF treatment in HSV-1 infected mice are efficient in reducing the
corneal angiogenesis alone, but not the corneal opacity.
To further determine the potency of ACF treatment in inhibiting the nuclear
localization of HIF-1α and HIF-2α in a non-immune and immune cell population, we
performed confocal imaging, and intracellular flow cytometry analysis on cornea
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samples from both groups (ACF and vehicle-treated) of HSV-1 infected mice. Our
results from flow cytometry analysis showed a significant decrease in the stabilization of
HIF-1α in the neutrophils and CD4 T cells in ACF treated group when compared to the
vehicle-treated group of mice at day 12 post-infection (Figure 21 A). Our results from
confocal images showed no stabilization of HIF-2α in the corneal epithelium of ACF
treated group at day 12 post-infection (Figure 21 B)
To study the immune influx in ACF treated a group of HSV-1 infected mice, the
corneas from both groups of HSV-1 infected mice were processed for flow cytometry
cell surface staining. Our results showed a decreased frequency of non-granulocytic
myeloid cells and CD4 T cells while an increased frequency of neutrophil influx was
observed in ACF treated a group of infected mice at day 12 post-infection (Figure 22)
Overall, these results highlight the efficacy of ACF treatment in modifying the
stabilization of HIF in immune and non-immune cell population and their role in
modulating the leukocyte subsets in HSV-1 infected corneas at the clinical disease
phase.
Discussion
Hypoxia has been well studied in association with inflammation in tissues [197].
The oxygen demand in the inflamed tissue is high due to the massive influx of
metabolically active neutrophils. This is one of the likely causes for the development of
hypoxia [216]. The process of neutrophil migration in the inflamed tissue requires an
abundant amount of energy [216, 217]. Remarkably, in the mouse model of inflamed
bowel disease, neutrophils are reported to shape the development of hypoxia.
Neutrophils in inflamed tissue carry out a mechanism of ‘respiratory burst’ executed by
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NADPH oxidase (NOX) activity. During this process, oxygen consumption is high and
therefore leads to the oxygen depletion in the local area.
Consequently, this causes inflammatory hypoxia [205]. Neutrophils play a crucial
role in HSK development. Reports have indicated a positive correlation between the
disease severity and increased influx of neutrophils in HSV-1 infected cornea [30]. In
support, we proposed a model illustrating the development of inflammatory hypoxia in
HSV-1 infected cornea. The newly formed blood vessels in the HSV-1 infected cornea
will supply molecular oxygen, while infiltrating neutrophils may likely cause the oxygen
depletion via NADPH oxidase activity causing hypoxia (Figure 23).
Hypoxia has been well reported to influence glucose metabolism due to the
increased energy demand in the inflamed tissue that harbors metabolizing active cells
[199]. A significant increase in the mRNA levels of glycolytic genes in HSV-1 infected
corneas was detected. The process of glycolysis is commenced by the uptake of
glucose which is carried out by the membrane-bound glucose transporters (GLUTs).
[218]. Among the various types of GLUTs, GLUT-1 has shown to be vital for CD4
function [219]. Recent reports have suggested that GLUT-1 is essential for CD4 T cells
in HSV-1 infected mice since the inhibition of glucose uptake reduced the HSK disease
severity [220]. Notably, our results showed membrane-bound GLUT-1 staining only in
the corneal epithelial cells but not in the corneal stroma which is heavily infiltrated with
CD4 T cells and neutrophils during the clinical disease of HSK. To our surprise,
prominent GLUT-3 staining was observed in the corneal stroma of HSV-1 infected mice.
Reports have indicated that GLUT-3 has a higher affinity for glucose than GLUT-1 [221].
Hence, our results discern the functionality of GLUTs in HSK cornea suggesting a
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crucial role of GLUT-3 in mediating glycolysis. Glycolytic cycle culminates with lactate
as its end product especially during hypoxia [222,223]. The lactate formed in the cytosol
is transported out of the cell via lactate transporter namely, monocarboxylate
transporters (MCTs). MCTs are present in different isoforms, among which MCT-4 is
highly upregulated in hypoxia [210]. A significant increase in the mRNA levels of the
MCT-4 gene, in correlation to the increased levels of lactate in HSV-1, infected corneas
was observed . This suggests, MCT-4 to be a designated exporter of lactate in the
corneas with HSK lesions. Lactate is a metabolic waste from glycolysis that is exported
out of the cell via MCT-4 and imported via MCT-1 as a metabolic fuel by cells
undergoing mitochondria respiration [224]. Our data showed an increased mRNA level
of MCT-1 gene in HSV-1 infected cornea (data not shown) as depicted in our proposed
model (Figure 23), HSV-1 infected corneas may probably have pockets of oxygenated
and hypoxic regions. In oxygenated regions mitochondrial respiration (tricarboxylic acid
cycle- TCA) predominates by conversion of pyruvate into acetyl CoA. At this point, we
infer from our results that lactate is a metabolic byproduct of glycolysis which serves as
an auxiliary metabolic fuel to promote mitochondrial respiration and survive through
hypoxia in HSK lesions. In support, our results also showed a significant increase in the
mRNA levels of Pdk1 that indicates an increased generation of acetyl CoA followed by
its entry into the TCA cycle in HSV-1 infected corneas. ‘Reductive carboxylation’ is
another way responsible for generating acetyl CoA derived from glutamine. It is known
that under a hypoxic condition or defective mitochondrial respiration, isocitrate
dehydrogenase-2 promotes glutamine-derived citrate synthesis. Citrate later gets
converted into acetyl CoA, thereby increasing the pool of acetyl CoA that may likely
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enter the fatty acid metabolism or continue through the TCA cycle [225,226].
Interestingly, our results show increased mRNA levels of the Idh2 gene, that is probably
executing the process of reductive carboxylation.
Stabilization (nuclear localization) of HIF-1α/ HIF-2α) is the hallmark of hypoxia.
The HIF isoform gets heterodimerized with HIF-1β and later gets translocated into the
nucleus to initiate the transcription of an array of genes involved in angiogenesis,
cellular metabolism, and apoptosis, etc. HIF-1α/ HIF-2α is known to have distinct
functions. HIF-1α is known to regulate glycolysis and promote expression of genes
encoding glucose/lactate transporters and glycolytic enzymes. While, HIF-2α may have
an indirect role in initiating glycolysis via c-Myc or related factors [227]. Therefore, this
indicates HIF-1α to possess a principal role in glycolytic metabolism [199,212]. Our
study shows the stabilization of both, HIF-1α/ HIF-2α, which implies that both isoforms
have a significant role in influencing mRNA levels of glycolytic genes in the corneas with
HSK lesions. Apart from its role in regulating cellular metabolism, HIF-1α is also known
as the ‘regulator of inflammation’ [212,213]. The HIF-1α expression has been
determined in the innate and adaptive cell population, whereas HIF-2α expression has
been studied in various cell types including the epithelial, endothelial and immune cells
[214,228,229,230]. Intriguingly, our study showed a differential expression of HIF-1α on
immune cell types including the myeloid cells, neutrophils, and CD4 T cells, while HIF2α was exclusively detected in the corneal epithelium of HSV-1 infected mice. Hence,
we conclude from our results that HIF plays an essential role in corneal inflammation.
We were further interested in studying the consequences of blocking the HIF function by
using acriflavine (ACF) in HSV-1 infected mice. ACF binds to both HIF-1α/ HIF-2α and
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inhibits its heterodimerization with HIF-1β which leads to the blocking of HIF
transcription activity [231,215]. We expected the blocking of HIF transcriptional activity
by ACF to alleviate the HSK disease severity. ACF action has been widely studied in
tumor models to reduce angiogenesis [215]. As expected, our results showed a
significant decrease in angiogenesis in the ACF treated group compared to the control
group of HSV-1 infected mice. Interestingly, these results correlated with the significant
reduction in the mRNA levels of the Pfkb3 gene (encoding glycolytic enzyme). Pfkb3 is
known to be HIF dependent and involved in promoting pathological angiogenesis since
its inhibition reduced the extent of the angiogenesis [232].
On the other hand, our results showed that ACF treatment aggravated the
corneal opacity. This was an unexpected result. Moreover, ACF treatment also showed
a significant increase in the influx of neutrophils in the corneas with HSK lesions.
Studies from HIF blocking have reported increasing the ROS levels in tumor models
[233]. ACF treatment may increase ROS levels due to an increased influx of neutrophils
in the corneas with HSK lesions. Hence, we concluded that ACF as a sole treatment is
not efficacious in alleviating the HSK disease severity.
In summary, our research demonstrates the development of inflammatory
hypoxia, correlating with the nuclear localization of HIF isoforms, and the prevalence of
glycolytic metabolism in corneas with HSK lesions. Additionally, our data indicate that
blocking HIF with ACF alone may not be potent in reducing HSK disease severity.
Overall, this study provides novel insights to promote the advancement of therapeutic
targets in targeting both, the blocking of HIF and inhibiting corneal inflammation.
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Figure 13: Development of inflammatory hypoxia corelates with influx of neutrophils in the
HSV-1 infected corneas.
A. Representative immunofluorescence and confocal images showing pimonidazole (hpi) staining
in uninfected (naive) cornea and HSV-1 infected corneas at 4-, 10-, and 15-, post-infection.
Prominent pimonidazole adduct staining (in green) is detected in infected corneas during clinical
disease period (10-day through 15-day post-infection). DAPI nuclear stain is shown in blue. FITCconjugated mouse IgG isotype control did not show hpi staining in infected cornea (Control 1).
Similarly, the HSK cornea from a mouse that did not receive pimonidazole injection, does not show
specific pimonidazole adduct staining in the cornea when stained with FITC conjugated antipimonidazole antibody (Control 2). The images shown were acquired with 40x objective, except the
control slides which were acquired with a 10x objective. DAPI nuclear staining in blue and
pimonidazole adduct staining (in green B. Representative FACS plots denote an increased
frequency of neutrophils (Ly6G+F4/80-) in HSV-1 infected corneas during the progression of clinical
disease at day 10 and day 15 post-infection. The progression of clinical disease was also
associated with a decrease in the frequency of macrophages (Ly6G-F4/80+) in infected corneas.
The frequency of neutrophils and macrophages was obtained from CD45+ leukocytes in infected
corneas. C. Scatter plot showing the quantification of pimonidazole staining in naïve and infected
corneas with mild and severe HSK at 10-day post-infection. This depicts the magnitude of hypoxic
regions (n=3 naïve corneas, n=8 mild HSK corneas, n=9 severe HSK corneas). Data derived is
shown from two similar experiments. p values were calculated using non-parametric Mann-Whitney
U test **** p≤0.0001
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Figure 14: Significant depletion of neutrophils correlated with reduced development of hypoxia in
HSV-1 infected corneas. A. Representative FACS plots denote the frequency of CD11b+ Gr1+
population in the splenocytes from isotype control, and anti-Ly6G treated groups of mice on day 12 postinfection. FACS plots were derived from live-gated cells. Scatter plots (right) denotes the frequency of
Gr1+ cells per spleen tissue from both groups of mice (open and closed circles) on day 12 post-infection.
Each circle represents an individual spleen tissue from HSV-1 infected mice (n=6). Figure legend
Continues
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Figure 14: Legend continues
B. Representative Eye image from the control group of mice at 12-day post ocular infection and a
corresponding corneal section showing pimonidazole staining (left). Representative Eye image from AntiLy6G treated mice at 12-day post ocular infection and corresponding frozen corneal section showing
pimonidazole staining. Bar graph (right) denoting the percentage of pimonidazole staining area (quantified
by using Image J software) in both groups of mouse corneas at 12-day post ocular infection.
Pimonidazole staining shown is representative of two independent experiments (n=5 corneas per group).
DAPI nuclear staining in blue and pimonidazole adduct staining (in green). Magnification X400.
C. Representative pseudocolor FACS plots demonstrating gating strategy to show singlets gated cell
population using the forward scatter height vs. area. Furthermore, live gated the cells using side and
forward scatter to distinguish three cell populations a) non-leukocytes b) Granulocytes c) CD4+ T cells.
Representative histogram FACS plots (top to bottom) denoting analysis of each of the cell population to
determine the mean fluorescence intensity (MFI) of pimonidazole compared to the isotype control (Black
line) in the control group (Magenta line) vs anti-Ly6G (blue line) treated group of mouse corneas at 12day post ocular infection. Scatter plot/bar graph (bottom panel) denoting pimonidazole MFI in all the three
histograms analyzed cell populations at 12-day post-ocular infection. Data derived is shown from two
similar experiments with n=5 per group. P values were calculated using unpaired non-parametric t-test. **
p≤0.01.
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Figure 15: Hypoxia Signaling Pathway RT2 Profiler Array to show elevated expression of
glycolysis regulating genes in the corneas with HSK lesions. PCR Array of hypoxia-associated
signaling pathway was carried out on naive, 5-day and 10-day post-infection cornea samples showed an
elevated expression of genes encoding glycolytic enzymes, glucose transporters, and the lactate
transporter at 10-day post-infection.
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Figure 16: Quantitative Real-Time Polymerase Chain Reaction Assay (RT-qPCR) to show elevated expression
of glycolytic genes in the corneas with HSK lesions.
RT-qPCR was carried out on uninfected and HSV-1 infected individual cornea samples. Bar graphs
document the fold change in the level of expression of (A) glycolytic enzymes (HK2, PFKP, PFKFB3), (B)
glucose transporters (Slc2a1 and Slc2a3), and lactate transporter (Slc16a3), (C) tricarboxylic acid cycle
genes (Pdk1, Cs, Idh2), (D) Pentose Phosphate Pathway genes (G6pd, Pgls, Pgd) in infected individual
corneas at 10-day POI in comparison to uninfected corneas. Data shown are representative of two similar
experiments (n=5 corneas/group). Statistical significance was calculated using parametric two-tailed
Student’s t-test.
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Figure 17: Prevalence of glycolytic metabolism in the HSV-1 infected corneas. A. Showing
membrane localization of GLUT-1 (Slc2a1), GLUT-3 (Slc2a3) and MCT-4 (Slc16a3) in infected corneas
with HSK at 10-day post infection. Naive and HSV-1 infected frozen corneal sections were stained with
anti-GLUT-1 (Slc2a1), GLUT-3 (Slc2a3) and MCT-4 (Slc16a3) antibodies followed by incubation with
Alexa-488 conjugated secondary antibody. Representative images document weak GLUT1 and MCT4,
but no GLUT3 staining in the corneal epithelium of naive corneas (top row). Intense GLUT-1 staining
was seen only in the corneal epithelium of infected eyes, whereas GLUT3 and MCT4 staining was
evident in epithelium and stroma of infected eyes at 10-day post-infection (bottom row). Image
magnification is at 400X. DAPI (blue, nuclear staining), GLUT-1, GLUT-3, MCT-4 (green). B.
Representative FACS plots denoting the frequency of CD4+ T cells (top panel), Ly6G + neutrophils
(bottom panel) in infected corneas at 10-day post-infection. The histogram FACS plots derived from the
gated population of CD4+ T cells and Ly6G+ neutrophils represent the expression level of MCT4
proteins in these immune cells. Scatter plot/bar graph (on right) demonstrate significantly increased
level of MCT-4 protein in neutrophils than CD4+T cells in infected corneas. C. Scatter plot is showing
significantly elevated level of L-lactate at 10-day post-infection in HSV-1 infected corneas than
uninfected corneas. Results shown are representative of three independent experiments (n=6-7
corneas or mice per group). Statistical significance was calculated using unpaired parametric Student’s
t-test (** p= 0.0058).
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Figure 18: Nuclear localization of hypoxia inducible factor-2α (HIF-2α) in the corneal epithelium
of HSV-1 infected corneas during clinical disease period. Representative immunofluorescence
images of frozen corneal sections showing HIF-2α staining obtained from the naïve (top panel), during
pre-clinical period (middle panel, 4-day post ocular infection) and clinical phase (bottom panel, 10-day
post ocular infection) of HSK. The top and bottom panel from left to right, showing nuclear staining with
DAPI (in red), HIF-2α staining (in green), and the merged images with nuclear localization of HIF-2α (in
yellow). Arrowheads in the bottom row indicate the epithelial cells with nuclear localization of HIF-2α in
yellow. Magnification X400. Immunofluorescence images shown are representative of five corneas at
each time-point.
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Figure 19: Stabilization of Hypoxia Inducible factor-1α and its differential expression on Immune
cell subsets in HSV-1 infected corneas. A. Representative pseudo color FACS plots of naïve cornea
denoting the gating strategy employed for CD45- leukocytes and CD45+ leukocytes. Representative
histogram FACS plot (right) to show isotype control and the level of intracellular HIF-1α protein in CD45and CD45+ populations, respectively. B. Representative pseudo color FACS plots of an infected cornea
at day-13 post ocular infection, denoting the gating strategy employed for CD45- leukocytes and CD45+
leukocytes, CD4 T cells, CD11b+ Ly6G+ neutrophils and CD11b+ Ly6G- myeloid cells. Representative
histogram FACS plot (top to bottom) to show isotype control and the level of intracellular HIF-1α protein in
CD4 T cells, neutrophils and myeloid cells, respectively in the infected cornea. Scatter plot/bar graph in
the top panel demonstrates the mean fluorescence intensity (MFI) of HIF-1α protein in CD45- and CD45+
leukocytes. Scatter plot/bar graph in the bottom panel demonstrates the MFI of HIF-1α protein in three
different immune cell populations in individual infected corneas at day-13 post ocular infection. Data
derived is shown from two similar experiments with n=5 per group. Statistical significance was calculated
used unpaired non-parametric t-test and one-way ANOVA test. **** p≤0.0001.
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Figure 20: Acriflavine treatment aggravates corneal opacity, but significantly reduces hemangiogenesis in corneas with Herpes Stromal Keratitis. A. Scatter plot (on the left) is showing the
corneal opacity score of individual corneas from control and acriflavine treated groups of HSV-1
infected mice at 10-day post-infection. B. Bar graph (right) is showing the incidence of eyes with
opacity score >3.0 between both groups of infected mice. C. Scatter plot is showing hem-angiogenesis
score of individual corneas from control and acriflavine treated groups of infected mice at 10-day postinfection. D. Scatter plot/bar graph is showing the expression of Pfkfb3 gene in individual corneas from
control and acriflavine treated groups of infected mice at 10-day post-infection. Statistical significance
was calculated using nonparametric Mann-Whitney U test. (n=5-6 HSV-1 infected mice per group in
each experiment).
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Figure 21: Acriflavine treatment significantly reduces stabilization of HIF isoforms (HIF-1/2α)
in the immune cell subsets and nonimmune cells respectively in HSV-1 infected corneas. A.
Representative pseudo color FACS plots demonstrating gating strategy to show singlets gated cell
population using the forward scatter height vs area. Furthermore, live gated the cells using side
and forward scatter to distinguish CD11b+ CD45+ Ly6G-, CD11b+ CD45+ Ly6G+ and CD11bCD45+ CD4+ cell populations. Representative histogram FACS plots (top to bottom) denoting
analysis of Neutrophils (CD11b+ Ly6G+) and CD4 T cells to determine the mean fluorescence
intensity (MFI) of HIF-1α in the vehicle (pink peak) vs acriflavine (ACF) treated (green peak) of
mouse corneas at 12-day post ocular infection. Scatter plot/bar graph (bottom panel) denoting HIF1α MFI in all the two histogram analyzed cell populations at 12-day post-ocular infection. Data
derived is shown from two similar experiments with n=5 per group. p values were calculated using
unpaired t-test. * p<0.05. B. Representative immunofluorescence images of frozen corneal
sections show HIF-2α staining obtained from the vehicle (top panel), ACF treated (bottom panel),
at 12-day post ocular infection) of HSK. The top and bottom panel from left to right, show nuclear
staining with DAPI (in red), HIF-2α staining (in green), and the merged images with nuclear
localization of HIF-2α (in yellow). Arrowheads in the top row indicate the epithelial cells with
nuclear localization of HIF-2α in yellow. Magnification X400. Immunofluorescence images shown
are representative of five corneas at each time-point. Data derived is shown from two similar
experiments with n=5 per group. p values were calculated using unpaired t-test. * p≤0.05.
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Figure 22: Acriflavine treatment significantly reduces the influx of non-granulocytic myeloid cells
and CD4 T cells in HSV-1 infected corneas. Representative pseudo color FACS plots demonstrating
gating strategy to show singlets gated cell population using the forward scatter height vs area.
Furthermore, live gated the cells using side and forward scatter to distinguish CD11b+ CD45+ Ly6G(non-granulocytic myeloid cells), CD11b+ CD45+ Ly6G+ (Neutrophils) and CD11b- CD45+ CD4+ cell
populations in vehicle vs Acriflavine (ACF) cornea treated samples. Scatter plot/bar graph (bottom
panel) denoting percentages of all three cell populations analyzed in vehicle vs ACF treated cornea
samples at 12-day post-ocular infection. Data derived is shown from two similar experiments with n=5
per group. p values were calculated using unpaired t-test.* p≤0.05, **p≤0.01, ***p≤0.001.
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Figure 23: A proposed model to demonstrate the development of inflammatory hypoxia in HSV-1
infected corneas during the clinical disease period. This model shows the existence of both,
oxygenated and hypoxic regions in the HSV-1 infected cornea. In the prevalence of hem-angiogenesis,
as one of the hallmarks of HSK disease, molecular oxygen will be likely supplied by these neo-blood
vessels formed in the HSV-1 infected cornea. However, in presence of massive influx of neutrophils, the
molecular oxygen may reduce into reactive oxygen species (ROS). Eventually, this process can shape
the development of inflammatory hypoxia.
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CHAPTER 2: EVALUATION OF EXTRA-ORBITAL LACRIMAL GLAND
AND CONJUNCTIVAL INFLAMMATION DURING HSV-1 INFECTION
Abstract
Corneal innervation, main lacrimal gland, and ocular surface components
including cornea, conjunctiva and meibomian gland act as a ‘functional unit’ that control
tear production via the neural reflex arc. Sensory corneal nerves are part of the neural
reflex arc, which regulates tear fluid production from the lacrimal gland. The loss of
sensory corneal nerves is reported in both human and mouse herpes stromal keratitis
(HSK). Chronic inflammation of the functional unit or one of its components may lead to
dysfunction in tear production. Our study showed a significant reduction in tear volume
in HSV-1 infected corneas of C57BL/6 (B6) mice during the clinical disease period. In
this study, we demonstrated that corneal HSV-1 infection in the B6 mouse model would
cause reduced tear levels in correlation to extra-orbital lacrimal gland (EoLG) and
conjunctival inflammation. Our study also ascertained the outcomes of decreasing tear
levels and their effect on lacrimal gland inflammation. Our results showed a massive
influx of CD45+ leukocytes involving CD4 and CD8 T cells and morphological changes
in inflamed EOLG tissues on day 10 post-infection. Most notably, the existence of the
replicating HSV-1 virus in the EoLG was detected on day 5 post-infection. Topical
administration of lacritin in HSV-1 infected mice did increase the tear volume at day 8
post-infection but was not able to sustain the increase in the tear volume throughout the
HSK disease phase. However, no change was observed neither in the influx of
leukocytes nor in the HSK disease severity (corneal opacity and hem-angiogenesis) in
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the lacritin treated group of HSV-1 infected mice. The conjunctival tissue was also
detected with an increased influx of leukocytes involving CD4 and CD8 T cells.
Interestingly, our results also showed a significantly reduced number of mucin
contributing goblet cells in the conjunctiva at day 10 post-infection, compared to the
uninfected(naïve) conjunctiva. Of note, these results correlated with the reduced tear
volumes in the HSV-1 infected mice at day 10 post-infection. Taken together, our study
suggested an increased leukocytes influx in EoLG and conjunctiva. Although lacritin
treatment alone delayed the decrease in tear volume in infected eyes, it was not
sufficient to inhibit leukocytes influx in EoLG of the HSV-1 infected mice. Additionally,
conjunctival tissue likely plays an important role in reducing tear volume after ocular
HSV-1 infection.
Introduction
HSK is an immunoinflammatory condition which persists in inflamed cornea even
after the clearance of infectious HSV-1 virus [234]. Studies from the mouse model have
reported the role of neutrophils and T cells in the pathogenesis of HSK [30,32]. The
hallmark of HSK in the mouse model involves the development of corneal opacity and
angiogenesis (hem- and lymphangiogenesis) [235,236]. Our data (Figure 24) and recent
studies in a mouse model of corneal HSV-1 infection have reported, the loss of sensory
corneal nerves during the progression of HSK [237,80]. The afferent sensory corneal
nerves are part of the neural reflex arc, which regulates the secretion of tear fluid on the
ocular surface [99,238].
The tear film is a thin transparent layer coating the surface of the eye [239].
There are three distinct layers in the tear film, comprising of the top lipid layer, middle
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aqueous and the inner mucin coat. The lipid layer is released from the meibomian
glands and harderian gland (in mice) to prevent the tear evaporation from the ocular
surface [240]. The aqueous layer is secreted by the lacrimal gland and helps in
providing nutrients and oxygen to the corneal tissue. Lacrimal gland plays an important
role in regulating the quantity and quality of tears overlying the corneal surface [99,124].
The goblet cells of the conjunctival epithelium secretes mucin contributing to the mucin
layer [241].
Additionally, the differentiated squamous cells with microvilli and microplicae, in
the superficial layers of the corneal epithelium, secretes glycocalyx and maintains the
tear film integrity [239,242]. Most of the tear film constitutes of the aqueous and mucin
layer [241]. Tear production is highly regulated by neural reflex arc, that consists of
parasympathetic and sympathetic innervations in the lacrimal gland that is activated by
the afferent sensory nerves in the cornea. The activation of neural reflex arc stimulates
the release of neurotransmitters from nerves innervating lacrimal gland and helps in
aqueous secretion onto the tear film overlying the ocular surface [243,244]. Acinar cells
are the main secretory cells of the lacrimal gland and surrounding these cells are the
myoepithelial cells [99]. EoLG is the prominent lacrimal gland in mice and rats [119].
Here, our study highlights on EoLG in the HSV-1 infected B6 mice. Overall, an intact
tear film is required to lubricate, supply the nutrients and helps in the diffusion of
atmospheric oxygen to the corneal epithelium.
It is well known that reduced tear level secretion leads to the irregularity in the
corneal surface due to the decreased lubrication of the corneal surface. Consequently, it
elevates the risk of damage to the corneal epithelium causing ‘dry eye’ like conditions
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[99]. This condition can be correlated to the persistent inflammatory conditions,
subsequently leading to the destruction of the EoLG [124]. Therefore, it is essential to
understand the histopathology of the EoLG in the B6 mice with HSV-1 infection.
Histologically, a normal EoLG consists of lobules that have multiple acini lined by
columnar secretory cells which play a major role in aqueous production (a prominent
layer in the tear film) released on to the ocular surface [245]. Under pathological
conditions EoLG is prone to undergo dysfunction with the infiltration of immune cells
(CD45+ /CD4+T cells) [124]. This causes a significant reduction in the exocrine function
of the EoLG resulting in decreased tear production and ocular lubrication [243]. Herein,
our study shows that chronic immuno-inflammatory disease caused by HSV-1 infection
in cornea will result in inflammation of the EoLG. This leads to an alteration in tear
production which will cause a direct impact on maintaining a moist ocular surface.
Topical administration of lacritin, an approach to increase tear secretion, transiently
increased the tear volume in the infected eyes during the early clinical disease phase of
HSK. Also, the treatment had a moderate, but not statistically significant, the effect in
reducing the severity of HSK.
Conjunctiva is a thin semitransparent mucous membrane that covers the
posterior surface of the eyelids and further extends into the limbus of cornea [246,129].
Conjunctival epithelium consists of the mucin-secreting goblet cells. Parasympathetic
and sympathetic innervation in conjunctiva is stimulated by corneal sensory nerves to
stimulate mucin secretion from goblet cells [135]. Conjunctival goblet cells have a key
role in mucin production, while its responses during HSV-1 ocular infection remain
unexplored. Infiltration of innate immune cells induces inflammatory responses in the
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conjunctiva. However, during HSV-1 infection in the cornea, there exists a paucity of
knowledge with the occurrence of conjunctival inflammation and its contribution in
maintaining the stable tear volume over the ocular surface. Our study suggests that
HSV-1 infection in B6 mouse cornea during clinical disease phase of HSK induces
conjunctival inflammation which results in the loss of goblet cells. Interestingly, reduced
tear volume correlates with the loss of goblet cells in the conjunctiva of HSV-1 infected
eyes. Altogether, the purpose of this study was to evaluate inflammation in extra-orbital
lacrimal gland and conjunctiva in the HSV-1 infected B6 mice.
Results
Loss of corneal nerves in HSV-1 infected eyes of C57BL/6 mice
The cornea is an avascular and highly innervated tissue. Corneal nerve damage
associated with the loss of sensation has been reported previously in HSV-1 infected
corneas [80]. The existence of corneal nerves plays an essential role in maintaining an
intact ocular surface by interconnecting with the neural reflex arc [247]. The cross-talk
between corneal nerves and the neural reflex arc is crucial in tear production [92,190].
Therefore, to elucidate the corneal innervation in HSV-1 infected eyes the cornea whole
mount of the naïve and HSV-1 infected eyes were prepared for staining with the panneuronal marker- anti-Tuj1 antibody, (as described in materials and methods). Several
reports have described corneal nerve formation, its distinct network and distribution
pattern in the normal cornea [92,80]. Our results from the montage images acquired
from the naïve (uninfected) cornea showed an intact network of nerves distributed from
the central cornea to the peripheral (limbus) region (Figure 24). Tuji1staining (green)
displayed the appearance of distinct thick nerve trunks in the limbal stromal region
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(Figure 24 A). These nerves further ramified into smaller branches as they reached the
paracentral region of the cornea (Figure 24 B). Prominent nerve leashes (bunches)
were identified throughout the montage image of the naïve cornea. The nerve leashes
further merged into the central cornea with fine branches forming a ‘central swirl’ pattern
(Figure 24 C). In contrast, the Tuj1 stained montages of HSV-1 infected cornea at day10 post-infection showed loss of corneal nerves, more prominently in the central cornea
(Figure 24 F) with the disappearance of distinct central swirl formation. Very faintly
stained thick limbal stromal nerve trunks were observed (Figure 24 D). No nerve
leashes in the paracentral region were observed (Figure 24 E) as compared to the
pattern in the naïve cornea. In conclusion, HSV-1 infected cornea had no prominent
staining of Tuj1 indicating the deinnervation or loss of corneal nerves that may likely
pose an impact on tear production.
Reduced volume of tears in HSV-1 infected eyes during the clinical phase of HSK
In mouse model, HSK is divided into pre-clinical (day -0 to -7 post-infection) and
clinical (day -7 to -18 post-infection) disease phase [31]. During the clinical phase, the
development of corneal opacity and angiogenesis is detected [235,237]. A study from
our lab (Figure 24) and recent studies, in a mouse model, have shown the loss of
sensory corneal nerves during the clinical phase of HSK [237,80]. The sensory corneal
nerves are part of the neural reflex arc, which regulates tear secretion from the lacrimal
gland [238]. To measure the tear volume in HSV-1 infected eyes, phenol red thread
(PRT) test was performed on infected eyes from C57BL/6 mice at different day postinfection, as described in Materials and Methods. PRT test was also carried out on eyes
with no ocular HSV1 infection (naïve). Representative phenol red thread images from
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naïve and day 10 post-infection are shown with the color change (yellow to red) on the
thread tips after the PRT (Figure 25 A). As shown in (Figure 25 A), an average of about
50% decrease in tear volume was measured in HSV-1 infected eyes on day 10, when
compared with an uninfected naïve group of mice. This experiment was carried out by
tracking the tear level in the same eye before and after corneal HSV-1 infection (Figure
25 A). Furthermore, the eyes with severe HSK (corneal opacity ≥3.0) were noted to
have a reduced level of tears than the eyes with mild HSK (corneal opacity ≤1.0) (Figure
25 A) Together, our results showed a significantly reduced tear volume in infected eyes
during the clinical phase of HSK compared to the uninfected eyes.
Histopathology of EoLG showing atrophy of acinar cells during clinical disease
phase of HSK
EoLG is the main contributor to the aqueous layer, which is the most vital layer of
the tear film [241]. Acinar cells in EoLG play a major role in tear secretion [99].
Therefore, impaired function in the acinar cells may cause a severe deficiency in tear
production. A recent study has highlighted the reduced tear volume and ‘destruction’ of
acinar cells in the EoLG of Sjorgen’s syndrome mice model [248]. Hence, we
hypothesized that acinar cell dysfunction might likely be the primary cause for the
reduced tear volumes in the HSV-1 infected B6 mice. To address this, histopathology in
EoLG was evaluated by Hematoxylin and Eosin (H&E) staining. EoLG were excised
from the naïve, at day-4 and -10 post-HSV-1 infection. The tissues were immediately
fixed using Excalibur’s fixative solution (as described in Materials and Methods). The
paraffin-embedded sections were later processed for H&E staining. Our results showed
acinar cell atrophy (circled areas in Figure 25 C) that was prominently observed in the
EoLG that is supplying tear to the eyes with severe HSK at day 10 post-infection
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compared to the uninfected control (naïve). Indeed, the EoLG tissue at day 10 postinfection failed to preserve the normal architecture as in control. On the other hand, the
EoLG which is supplying tears to the eyes with mild HSK showed infiltration of fewer
inflammatory cells in the interstitium of the EoLG (Figure 25 C). H&E staining in the
naïve showed compactly arranged acini in the lobules. A similar observation was noted
in the EoLG at day 4 post-infection (Figure 25 C). Eye images depicting HSK disease
severity and phenol red thread test images are shown in the (Figure 25 C) which
correlates to the histopathology of EoLG. Altogether, our data suggest degeneration of
acinar cells in the EoLG, which correlates with reduced tear volume in the eyes of HSV1 infected mice during the clinical phase of HSK.
Increased influx of leukocytes in EoLG of HSV-1 infected eyes during the clinical
phase of HSK
EoLG play an important role in regulating the quantity and quality of aqueous
component of the tear fluid in mouse [249]. In several pathological instances, EoLG is
excessively infiltrated with immune cells, which may cause damage to acinar cells
resulting in an insufficient tear production [250,251]. To determine whether corneal
HSV-1 infection promotes leukocyte influx in EoLG, HSV-1 infected C57BL/6 mice were
euthanized on the day -4 and -10 post-infection and EoLG was collected to perform flow
cytometry. As is shown in our results (Figure 25 B), an average of about 3-fold increase
in the frequency and an absolute number of CD45+ cells were seen in EoLG on day-10
in comparison to day-4 post-infection. Among CD45+ cells, more than 5-fold increase in
the average number of CD4 and CD8 T cells was determined in EoLG on day-10 than
day-4 post-infection. Our results showed an increased influx of T cells in EoLG of HSV1 infected mice during the clinical phase of HSK.
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Detection of Replicating virus in the EoLG tissue of HSV-1 infected B6 mice
during the pre-clinical disease phase of HSK
The replicating HSV-1 virus exists in cornea until day 5 to day 6 post-infection,
after which clearance of the replicating virus occurs [203]. EoLG is innervated with both
parasympathetic and sympathetic nerves. One of the ophthalmic branches of the
trigeminal nerve (V1) sub-branches into the lacrimal nerve that enters the lacrimal
gland. It is noteworthy to mention that the ophthalmic branch is interconnected with the
sensory nerves of the cornea and the lacrimal nerve in the EOLG [252]. Therefore, we
hypothesized that the replicating HSV-1 virus during the pre-clinical phase of HSK
disease could possibly re-route towards the V1 branch and enter EoLG via the lacrimal
nerve. Eventually, the residing infectious virus in the EoLG can evoke inflammation and
cause tissue damage. Our results so far have indicated excessive tissue damage with
the significantly increased influx of leukocytes in the EoLG of HSV-1 infected mice. To
further elucidate the existence of the infectious virus, the excised EoLG from the day 5
and day 10 post- HSV-1 infected mice were minced in one/two small pieces and cocultured with the Vero cell monolayer tissue culture flask (Figure 26 A). After the 48
hours of incubation, these Vero cell cultures were examined for phenotypic changes.
Notably, EoLG at day 5 post-infection showed predominant changes in the phenotype of
Vero cells which were the typical characteristics of virus infection. As shown in (Figure
26 B) the confluent layer of Vero cells starts getting peeled off the adherent surface and
the rounding of cells occur. In contrast, EoLG at day-10 post-infection neither showed
any symptoms of virus infection nor depicted any of the above-mentioned phenotypic
changes in the Vero cell monolayer (Figure 26 C). The control showed the normal and
healthy growth of Vero cell monolayer adherent to the surface (Figure 26 D).
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To further quantitate the viral load in EoLG of HSV-1 infected mice during the
pre-clinical disease phase, we carried out a viral titration assay. This assay was used to
quantify the number of plaque forming units (PFU) from the individual EoLG of
naïve(uninfected) and HSV-1 infected mice at day-5 post-infection. A significant
increase in the PFU at day 5-post-infection was observed compared to the naïve
(uninfected control) (Figure 26 E). Of note, these results correlated with our previous
result that showed phenotypic changes in the Vero cell monolayer co-cultured with day
5 post-infection EoLG. Altogether, our findings indicate the existence of the replicating
virus in the EoLG of HSV-1 infected mice.
Lacritin treatment delayed but did not prevent the reduction in tear volume nor
reduced the severity of HSK in HSV-1 infected C57BL/6 mice
Lacritin is a tear glycoprotein, which has been shown to increase tear production
in aqueous-deficient dry eye disease [253]. To determine if lacritin treatment could
increase the tear level in HSV-1 infected eyes, topical administration of lacritin and its
truncated control peptide (C-25) was carried out on HSV-1 infected eyes, as described
in the Materials and Methods. A brief outline of the lacritin treatment conducted is
shown in (Figure 27 A). HSV-1 infected eyes, receiving topical lacritin treatment,
showed a significantly higher level of tears in comparison to truncated C-25 treated
control group of infected mice on day 8 post-infection. However, the effect of lacritin
attenuated with the progress of time, and on day 10 post-infection no significant
difference in the level of tears was measured between treated and control groups of
infected mice (Figure 27 A). No significant difference in the frequency and number of
leukocytes infiltrating EoLG of infected mice was detected on day 10 post-infection
when compared between both groups of mice (Figure 27 B). Although a reduced
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corneal opacity was observed in lacritin treated than control C-25 treated HSV-1
infected eyes on day 10 post-infection, the data was not statistically significant.
Furthermore, the lacritin treatment alone was not effective in preventing the loss of
corneal epithelium smoothness observed in HSV-1 infected eyes during the clinical
disease period (Figure 27 C). Together, our results showed that Lacritin, but not C-25,
treatment effectively delayed the decrease in tear volume in infected eyes. Lacritin
treatment given alone to HSV-1 infected eyes had a moderate, but not statistically
significant effect on reducing the severity of HSK.
Loss of goblet cells in the conjunctiva of HSV-1 infected eyes during the clinical
phase of HSK
Conjunctival epithelium has specialized cells secreting mucins namely, the goblet
cells. Mucins are the vital component of the tear film and hence crucial in maintaining
the tear film overlying the corneal epithelium [254]. Reports have implied that dry eye
conditions lead to a reduced number of goblet cells in the conjunctiva of mouse models
[255]. In the agreement, our data showed a significant reduction in the tear volume in
the eyes of HSV-1 infected mice (Figure 28 A) that potentially may cause dry eye
conditions. Concerning this result, it was important to evaluate the mucin-secreting
goblet cells in the conjunctiva of the HSV-1 infected eyes. Mucin secretion in
conjunctival goblet cells was evaluated by periodic acid-Schiff (PAS) staining. Adnexa
was excised from the naïve and at day-4, -10 post-HSV-1 infections. The tissues were
immediately fixed using Excalibur’s fixative solution (as described in materials and
methods). The paraffin-embedded sections were later processed for PAS staining. Our
results showed distinct staining of PAS+ goblet cells in the naïve and at day 4 postinfection lined along the conjunctival epithelium (as indicated by the arrows, Figure 28
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A) at the fornix and superior to the fornix region. On the contrary, loss of goblet cells
was observed in the conjunctival epithelium of HSV-1 infected eyes at day 10 postinfection. Intriguingly, the loss of goblet cells correlated with the reduced tear volumes
corresponding to the HSK disease severity (Figure 28 A).
To further enumerate the number of goblet cells, quantification of the goblet cells
in the conjunctiva of naïve, at day-4, and -10 post-infection was performed using the
Image J software. The PAS+ goblet cells were counted per microscopic field
(0.01mm2). A significant reduction in the number of PAS+ goblet cells was observed in
the conjunctiva at day-10 post-infection compared to the naïve or at day-4 post-infection
(Figure 28 B). Approximately 75% of the goblet cells were lost in the conjunctiva at day10 post-infection. Our results confirm the loss of goblet cells in the conjunctiva of HSV1 infected eyes that may cause dysfunction in the mucin secretion and in the
maintenance of tear film integrity.
Increased influx of leukocytes in the conjunctiva of HSV-1 infected eyes during
the clinical phase of HSK
As mentioned earlier, conjunctiva has a prominent role in maintaining a moist
and lubricated ocular surface by secretion of mucins. However, during inflammation
dysfunction in the mucin secretion may occur causing dry eye conditions and damage to
the ocular surface. Reports have indicated an increased infiltration of T cells in the
conjunctiva during dry eye conditions [256]. Since our results confirmed the loss of
goblet cells, we were further interested in characterizing the influx of leukocytes in the
conjunctiva of HSV-1 infected eyes by using flow cytometry. The excised adnexa from
the naïve, at day -4, and -10 post-infection were collected, and bulbar conjunctiva was
dissected. The pooled conjunctiva samples were then processed into single cell
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suspensions and stained with cell surface antibodies as mentioned in the materials and
methods. As is shown in our results (Figure 29), an average of about 3-fold increase in
the frequency of CD4 T cells and an average of 1-fold increase in CD8 T cells were
observed in the conjunctiva on day 10 in comparison to day 4 post-infection. Our results
demonstrated an increased influx of T cells in the conjunctiva of HSV-1 infected mice
during the clinical phase of HSK.
Discussion
Our findings in this study showed reduced tear levels in HSV-1 infected eyes in
association with inflammation in EoLG and conjunctiva. The extent of inflammation
correlated with the severity of HSK, and the reduced volume of tears in HSV-1 infected
eyes. We also noted the atrophy of acinar cells in the EoLG of infected mice with severe
HSK. Our approach to increasing the tear volume, while using topical lacritin treatment,
transiently increased the tear fluid level in HSV-1 infected eyes. Also, lacritin treatment
partially but not significantly reduced the extent of hypoxia, and the severity of HSK.
Recent reports [237,80] and our results (Figure 24) indicated an extensive loss of
sensory corneal nerves in HSV-1 infected eyes during the clinical phase (day 10 postinfection) of HSK. The bulk of aqueous tear fluid production is contributed by the
lacrimal gland and is tightly regulated by the neural reflex arc (NRA) [99]. The NRA
includes afferent sensory corneal nerves and parasympathetic and sympathetic
innervations of the lacrimal gland [257]. Inputs and outputs from the sensory corneal
nerves are reported to control the tear fluid secretion from the lacrimal gland [238].
Since sensory corneal nerves are involved in regulating tear production from the
lacrimal gland, their loss in HSV-1 infected eyes will likely affect reducing the tear
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secretion from the lacrimal gland, as shown in our results. In latent stromal herpetic
keratitis patients, the steady-state turnover of tears is also significantly reduced and is
considered to be the outcome of impaired lacrimation [258]. In aqueous deficient dry
eye condition, lacrimal gland (LG) inflammation is associated with the reduced aqueous
production of tears [124]. LG inflammation may also cause the atrophy of acinar cells.
Our results showed a massive influx of CD4 and CD8 T cells, and the atrophy of acinar
cells in EoLG of infected mice with severe HSK. Although the cause of increased
infiltration of leukocytes in EoLG is not clear, the loss of sensory corneal nerves in HSK
developing eyes may play a role in lacrimal gland inflammation. Sensory corneal nerves
regulate neurotransmitter, such as acetylcholine and norepinephrine, secretion from the
parasympathetic and sympathetic innervations in EoLG. It is possible that degeneration
of sensory nerves in corneas during the clinical phase of HSK may cause a decrease in
the release of neurotransmitters from the nerves in EoLG, and this may result in an
excessive influx of T cells in lacrimal gland [99]. Pharmacological blockade of
acetylcholine receptor has been shown to cause inflammation and lymphocytic
infiltration in EoLG of B6 mice [259]. Interestingly, during inflammation reports have
suggested the occurrence of fibrosis [260]. The process of fibrosis involves a massive
deposition of extracellular cellular matrix components. In inflamed lacrimal gland, acinar
cells were reported to be replaced by the ‘hyaline fibrous tissue’ [261]. In Sjogren's
syndrome, the lacrimal gland was detected with ‘intralobular fibrosis’ associated with
increased deposition of fat [252]. Therefore, we hypothesize that EoLG in HSV-1
infected mice with severe HSK may be undergoing the process of fibrosis in association
with the degeneration of acinar cells. As our result showed (Figure 25 B), a distorted
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architecture of the EoLG, likely indicates the replacement of acinar cells with massive
deposition of fibrous tissue.
Lacritin is a tear glycoprotein which has recently been shown to promote the
basal tearing in normal rabbits [262]. Besides, the topical application of lacritin
effectively increased the tear secretion in aqueous-deficient dry eye disease [253]. In
HSV-1 infected eyes, lacritin treatment transiently increased the tear volume, but the
effect was attenuated by day 10 post-infection. This suggests that lacritin treatment
alone is not highly effective in controlling HSV-1 induced inflammation of the EoLG. In
HSK, the corneal stroma is heavily infiltrated with immune cells [263], and the latter
causes stromal inflammation. In response to chronic stromal inflammation, the corneal
epithelial cells may adopt an aberrant cell fate [264]. Therefore, this may have an
impact on maintaining an intact tear film. The formation of an intact tear film on the
corneal surface is important to preserve the corneal epithelium homeostasis. Although,
lacritin is suggested to promote the corneal epithelium homeostasis [265]. lacritin
treatment in association with an approach to control stromal inflammation should be
more effective in reducing the severity of HSK.
Conjunctival goblet cell secretion is interconnected with the neural reflex arc. The
stimulation from the reflex arc initiates goblet cells to secrete mucins which are largely
the membrane-bound type of mucins. Muc16 is transmembrane mucin, while Muc5a/5b
are the large secretory mucins expressed by the goblet cells in mouse conjunctiva
[266]. Mucins in the tear film play a major role in maintaining tear film integrity and a
lubricated ocular surface [267]. However, in dry eye syndrome, reduced mucin secretion
has been reported in correlation to the reduced number of goblet cells [242]. Our study
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demonstrated a loss of corneal sensory nerves followed by the reduced tear volumes in
the HSV-1 infected eyes. In our study, most likely due to prevalent dry eye conditions,
loss of goblet cells in the conjunctiva of HSV-1 infected eyes were observed. This
provides us the clues on dysfunction in mucin secretion that may directly impact the
integrity of the tear film and the ocular surface. Reports have indicated a significant loss
of mucin-secreting goblet cells during inflammation and in aqueous-deficient dry eyes
[268]. In mouse models, IFN-γ is known to promote loss of goblet cells [269]. Studies
have indicated that dry eye conditions augment the expression of IFN-γ, which indeed
causes loss of goblet cells [268]. IFN-γ is produced by CD8 T cells Th1 lymphocytes
and other cell types [270]. Increased infiltration of T cells in the conjunctiva during dry
eye conditions has been reported [256]. A significant increase in the influx of T cells in
the conjunctiva of HSV-1 infected eyes was observed. Although the cause for loss of
goblet cells is unclear in the conjunctiva of HSV-1 infected eyes, it is likely possible that
the influx of T cells (CD4/CD8) are the culprits involved in causing degeneration of
conjunctival goblet cells. This provokes a vicious cycle of events initiated by a dry ocular
surface that leads to an increased influx of IFN-γ producing T lymphocytes,
subsequently causing loss of conjunctival goblet cells. Of note, ‘Squamous metaplasia’
is a pathological phenomenon detected during the loss of goblet cells and impacts the
health of ocular surface [271,272]. In the presence of dry eye conditions and existing
chronic inflammation in the HSV-1 infected mice, squamous metaplasia may likely
hamper the integrity of the tear film and the corneal epithelium causing loss of vision.
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In summary, this study broadens our knowledge to further explore the cause for
acinar cell degeneration and the loss of conjunctival goblet cells during lacrimal and
conjunctival inflammation respectively, in HSV-1 infected mice.
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Figure 24: Deinnervation in HSV-1 infected cornea. Representative Confocal images of Tuj-1 stained
corneas. Corneal whole mount staining was performed for determining the existence of corneal nerves by
using Tuj 1- neuronal marker. Montage images were acquired at 200x magnification. The enlarged
images of each region from montage are shown in the insets respectively. In the Naïve cornea an intact
nerve pattern was observed in the limbus showing thick limbal stromal nerve trunks (A); in the paracentral region showing nerve leashes (bunches) running in an orientation parallel to each other
throughout the whole corneal mount (B). The nerve bunches ramified into fine branches and merged into
the central corneal region (C) as displayed in the montages. In day 10 HSV-1 infected cornea, loss of
corneal nerves was observed. There are was no intact distribution of nerves compared to the naïve
cornea. Very faintly stained stromal nerve trunks were observed (D); no nerve bunches displayed in the
para-central region (E); loss of corneal nerves in the central region (F). TUJ1 (green).
Immunofluorescence images shown are representative of three corneas at each time point.
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Figure 25: Significant reduction of the tear volume correlating with inflammation in Extra-orbital
lacrimal gland in HSV-1 infected corneas during the clinical phase of HSK. A. Representative
Images of phenol red threads used for measuring the tear volume in the eyes of naïve and at day 10
post-infection. The color change in threads from yellow to red depicts the tear volume. Scatter plots
designated with colored dots represent basal tear volume in the individual naïve mouse eye followed by
day 7 and day 10 POI (post-ocular infection). Each colored dot in the scatter plot corresponds to the tear
volume (basal, day7 and day10 POI) of individual mouse eyes. The Bar graph on the far left is showing a
significant reduction in the measurement of the tear volume in eyes with severe HSK compared to the
mild HSK. Figure legend continues

101
Figure 25: Legend continues
B. Representative hematoxylin and eosin (H&E) staining in the paraffin sections of EOLG excised from
the naïve, HSV-1 infected mice at day 4 post-infection and at day 10 post-infection with mild HSK (top)
and severe HSK (bottom). Eye images depict the severity of corneal opacity correlating to the phenol red
thread images with the measurement of reduced tear volume in severe HSK eyes. Circled areas in EOLG
of infected mice with severe HSK demonstrate the atrophy of acinar cells. C. Representative FACS plots
denote the frequency of CD45+ cells (top panel) and CD4/CD8 T cells (bottom panel) in EOLG of HSV-1
infected mice on 4 and 10-day post-infection. Scatter plots demonstrate a significant increase in the
frequency and an absolute number of total leukocytes (top panel) and CD4/CD8 T cells (Bottom panel) in
EOLG of infected mice on day10 than day 4 post-infection. Results shown are representative of two
similar experiments. (n=5 to 8 eyes per group). Statistical analysis was performed by using unpaired twotailed Student’s t-test and one-way ANOVA, (*p≤0.05, **p≤0.01, ****p≤0.0001, nsp>0.05).
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Figure 26: Detection of Infectious virus in the Extra-orbital lacrimal gland of HSV-1 infected B6
mice at the preclinical disease phase of HSK. A. Representative image of the tissue culture flask with
Vero cell monolayer, co-cultured with excised EoLG (minced into two tiny pieces) from HSV-1 infected
mice at day-5 or day-10 HSV-1 post-infection. B. Representative image of the monolayer layer of Vero
cells after 48hr co-culture with EoLG tissue excised from HSV-1 infected mice at day 5 post-infection.
Phenotypic changes (rounding off cells and peeling off the adherent surface) in the Vero cells can be
observed prominently. Image magnification at 10x taken to view prominent changes in the Vero cells in a
larger area of the monolayer. C. Representative image of the monolayer layer of Vero cells after 48hr coculture with EoLG tissue excised from HSV-1 infected mice at day 10 post-infection. No phenotypic
changes were observed in the monolayer of Vero cells. D. Image is showing the normal Vero cell
monolayer as a control. D. Viral titration assay was carried to quantify the number of the plaque forming
units (PFU) from the individual EolG of naïve(uninfected) and HSV-1 infected mice at day-5 postinfection. A significant increase in the PFU at day 5-post-infection was observed. (n=5 for each time point
post-infection). Statistical analysis was performed using unpaired two-tailed Student’s t-test and one-way
ANOVA; The p values were calculated using unpaired two-tailed Student’s t-test (*p≤0.05).
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Figure 27: Topical administration of Lacritin transiently increases the tear volume and partially
reduces the severity of HSK in HSV-1 infected corneas. A. Schematic of topical lacritin/C-25
treatment regimen started at day 4 through day 10 post-infection. Images of Phenol Red Thread (PRT)
test from C-25 control and Lacritin treated group of HSV-1 infected mice. The PRT test was performed
to test the basal tears (before HSV-1 infection) and at day -6, -8, and -10 post-infection. Scatter plots
represents the tear volume measured in C-25 (control) and lacritin treated groups of HSV-1 infected
mice. Significant increase in the tear volume was observed at day 8 post-infection. B. Representative
FACS plots denote the frequency of CD45+ cells (left panel) and CD4/CD8 T cells (right panel) in
EOLG of C-25 (top panel) and lacritin (bottom panel) at day 10 post-infection. Scatter plots show no
significant difference in the frequency and absolute number of CD45 (top panel) and CD4/CD8 T cells
(bottom panel) in EOLG derived from both treated groups of mice. C. Scatter plot shows the corneal
opacity score and angiogenesis score of individual mouse eye between both groups of mice at day-6, 10 post-infection. Scatter plot shows the corneal smoothness scores of individual mouse eye between
both groups of mice at 6,8 and 10 –day post-infection. Data shown are representative of two
independent experiments. (n=5 to 8 eyes per group). The p values were calculated using unpaired twotailed Student’s t test (*p≤0.05, nsp>0.05).
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FIG 28: Loss of goblet cells in the conjunctiva of HSV-1 infected cornea during the clinical phase
of HSK. A. Infected eyes with ocular adnexa were surgically excised from the naïve C57BL/6 mice and
on day 10 post-infection. The paraffin sections of eyes with surrounding eyelids were stained with periodic
acid Schiff's (PAS) for the identification of goblet cells. Sections were deparaffinized before staining.
Arrows indicate the regions in the conjunctiva (superior to fornix) with PAS-stained -goblet cells in the
naïve (uninfected), at day-4 and -10 post-infection. Eye images and the thread test corresponds to the
respective adnexa. Bar graphs showing the quantification of goblet cells in 0.1mm 2 performed using
Image J software. B. A significant decrease was observed in the goblet cell number of the conjunctiva at
day 10 post-infection. (n=4 to 6 eyes per group). The p values were calculated using one-way ANOVA
ns

(*** p≤0.001, p>0.05).
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Figure 29: Increased infiltration of leukocytes in the conjunctiva of HSV-1 infected cornea
during clinical phase of HSK. Representative FACS plots denote the frequency of CD45+ cells (top
panel) and CD4/CD8 T cells (bottom panel) in the conjunctiva of HSV-1 infected mice on 4 and 10-day
post-infection. B. Scatter plots show frequency and absolute numbers of total leukocytes (top panel)
with a significant increase in the frequency and absolute numbers of CD4/CD8 T cells (bottom panel)
in the conjunctiva of HSV-1 infected mice on day 10 than day 4 post-infection (bottom panel). Data
shown are representative of two independent experiments. (n=5 to 8 eyes per group). The p values
ns

were calculated using unpaired two-tailed Student’s t test (*** p≤0.001, *p≤0.05 , p>0.05).
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CHAPTER 3: MORPHOLOGICAL ALTERATIONS IN THE CORNEAL
EPITHELIUM DURING OCULAR HSV-1 INFECTION
Abstract
Corneal epithelium consists of non-keratinizing stratified squamous epithelium
which plays an essential role in maintaining a transparent cornea, thereby providing a
clear vision. However, previous reports have shown that during HSV-1 infection
aberrant corneal epithelial differentiation occurs, resulting in the loss of corneal
epithelial characteristics. Here, we hypothesized that non- keratinized corneal
epithelium acquires a keratinized ‘skin-like epithelium’ (epidermis) in HSV-1 infected
corneas that directly hinders clear vision and leads to corneal blindness. The previous
study reported from our laboratory suggested reduced tear volume in the HSV-1
infected eyes of C57BL/6 (B6) mice during the clinical disease phase. The reduced tear
volume also increases desiccation in the eyes leading to ‘dry-eye’ condition. Our study
showed reduced smoothness in the HSV-1 infected cornea in association to positive
Rose Bengal staining indicative of dry eye and damaged ocular surface. It is known that
intact non- keratinized corneal epithelium plays a major role in maintaining a moist and
conditioned ocular surface. Corneal epithelial cytokeratin-K12 is one of the key proteins
that function to maintain epithelial integrity and homeostasis. Therefore, in this study,
our interest was to understand the characteristic expression pattern of cytokeratins in
the corneal epithelium of HSV-1 infected eyes. Interestingly, our results showed the
reduced or loss of corneal epithelial specific K12 keratin expression, while the
appearance of epidermis-specific K10 expression was observed as the disease
progressed during the clinical phase of HSK. To our surprise, the loss of paired box
protein (Pax-6) expression indicative of abnormal differentiation of ocular surface
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lineage was also observed in the HSV-1 infected corneal epithelium during the clinical
phase of HSK. Overall, this study highlights a novel finding on the trans-differentiation of
non-keratinized corneal epithelium to the keratinized epidermis type, in association with
the loss of Pax-6 expression during the clinical phase of HSK disease.
Introduction
The cornea is an avascular tissue, which will receive oxygen supply and
nourishment from the tear film in the anterior region and aqueous humor in the posterior
region [43,44]. One of the hallmarks of HSK disease in mouse cornea includes damage
of corneal nerve associated with corneal epithelial defect [237]. Corneal nerve damage
is associated with the loss of corneal nerve fibers extending from the corneal stroma
into the epithelium [237]. Previous results from our lab also showed a similar outcome of
loss corneal nerves at day 10 post-infection in HSV-1 infected B6 mouse cornea [Figure
24]. The cornea is a densely innervated tissue. The abundant nerve supply with its
density and pattern of branching is important in maintaining the corneal integrity and
homeostasis of corneal epithelium [80]. Corneal nerves play a predominant role in tear
production and in maintaining the corneal epithelial integrity [273]. Reduced sensory
corneal nerves will result in the loss of sensation and a decrease in the density of
superficial corneal epithelial cells [273]. The loss of corneal nerves will reduce the ability
of efficiently providing oxygen to a corneal tissue that manifests in ‘dry eye’ conditions.
The dry eye can either be due to tearing deficiency or increased tear evaporation in the
absence of intact corneal epithelium [274]. Therefore, production of the tear film with its
maintenance over the intact corneal epithelium is essential to keep a moist and
conditioned ocular surface. To evaluate the corneal smoothness, HSV-1 infected eyes
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were scored as described in Materials and Methods. A significant increase in the
smoothness score was observed, suggesting an increased corneal surface damage
(Figure 30 B). In clinics, Rose Bengal staining has been widely used to detect ocular
surface damage associated with tear film breaks or with compromised tear film integrity
[a 275]. Our results showed purple san stained areas in HSV-1 infected eyes at day 10
post -infection but not prominent in the uninfected eyes (Figure 30 A). Rapid corneal
epithelial cell turnover has been reported with the increased thickness in dry eyes [276].
The data from our study showed increased proliferation detected by BrdU
(BromodeoxyUridine) (Figure 31 A). BrdU is a proliferation marker, which incorporates
into replicating DNA [263]. Further, it is detected by staining with anti-BrdU antibody and
is imaged using a confocal microscope as detailed in Materials and Methods.
Damage or loss of corneal nerves has been reported to show reduced levels of
tears [277], but its influence on corneal epithelial cytokeratin expression has not been
studied. Cytokeratin expression on the corneal epithelial cells functions to maintain the
epithelial integrity, mechanical stability through their interaction with the tight junction
proteins [67,278]. Hence, it is important to study the expression pattern of cytokeratin in
the corneal epithelium. In our study, we investigated the abnormalities in the corneal
epithelial keratin (K12) expression during HSV-1 infection. Our results showed abnormal
expression or the loss of K12 with the appearance of K10 (epidermis-specific) in the
corneal epithelium of HSV-1 infected eyes at day 10 post-infection (Figure 32, 33).
Studies from other groups have also shown that reduced K12 expression is detected in
correlation to reduced Pax-6 expression [279]. Pax-6 is a transcription factor which
plays an essential role in the development and maintenance of ocular lineage. More
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precisely, Pax-6 is crucial in maintaining the corneal phenotype, since Pax-6+/- mice
showed reduced expression of K12 [280]. Our results showed that, in association with
abnormal K12 expression, loss of Pax6 expression in HSV-1 infected cornea was
observed during the clinical phase of HSK (day 10, 16 post -infection) (Figure 34).
Overall, based on our previous observation of reduced tear volume in HSV-1
infected eyes, our study sheds light on alterations in the morphology of corneal
epithelium. Mainly, the changes in the corneal epithelium as observed by the loss of
corneal epithelial specific cytokeratin K12 and the appearance of the epidermis-specific
K10 is a novel finding in the HSV-1 infected eyes. Intriguingly, these results
corroborated with the loss of Pax6 in the corneal epithelium of HSV-1 infected eyes
which is crucial in eye development. Therefore, this study emphasis on n the
morphology and maintenance of corneal epithelial integrity which plays a major role in
both, tear secretion and its maintenance over the corneal surface.
Results
Irregular corneal smoothness and damage to the ocular surface epithelium in the
HSV-1 infected eyes
A smooth and conditioned corneal surface is maintained in the presence of intact
underlying corneal epithelium. Based on our previous results that showed reduced tear
volumes, we were curious to understand the smoothness of the corneal surface in HSV1 infected eyes. Corneal smoothness scoring was employed to understand the extent of
corneal surface irregularity and was evaluated as described in materials and methods.
Briefly, corneal smoothness score wan as evaluated on a five-point scale depending on
the distorted quarters of the reflected ring: 0- no distortion, 5- severe distortion [281].
The corneal smoothness for each eye in the uninfected (naïve), at day- 4, -8, and -10
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post-infection were recorded. Representative eye images of the naïve, at day 4 and day
10 with the reflecting ring is shown in (Figure 30 A). Our results showed a sign
significantly increased smoothness score in the eyes during the clinical phase of HSK
(day 10 post-infection) compared to the naïve with a score of zero (Figure 30 B). An
average of 2-fold increase in the corneal smoothness scores was observed at day 10post-infection compared to the naïve (Figure 30 B).
We were further curious to elucidate the irregularity in the corneal surface. This
was determined by using Rose Bengal staining in the naïve and at day 4 and 10 postinfection. Rose Bengal staining is observed in a damaged and dry corneal surface.
Positive Rose Bengal staining indicates damage to corneal epithelium and is routinely
used in clinics to diagnose dry eye syndrome [275]. Our results showed a prominent
magenta/ dark pink punctate staining on the corneal surface in the eyes at day 10 postinfection, while faint staining in day 4 post-infection eyes, compared to no staining in the
naïve (Figure 30 A). Taken together, our data suggest the prevalence of ocular surface
damage indicative of dry eye conditions in HSV-1 infected eyes.
Hyperproliferation of corneal epithelium during the clinical onset of HSK
Immunofluorescence staining for BrdU was performed as described in Materials
and Methods to characterize the extent of proliferation in the corneal epithelium of HSV1 infected eyes. As a marker for proliferation, the nuclear staining of BrdU indicates
rapidly diving cells. Based on our previous observation (Figure 31 A), we hypothesized
that rapid corneal epithelial cell proliferation might likely be stimulated to compensate for
the ocular surface damage. Therefore, we sought to study the magnitude of proliferation
in the corneal epithelium of the naïve and at day 5 and 9 post-infection. The nuclear
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staining with BrdU was prominent in the corneal epithelium as shown in the tile scan
image (Figure 31 A) compared to the corneal epithelium at day 5 post-infection. The
enlarged images acquired at high magnification shows intensely stained BrdU+ cells
(Figure 31 A). No BrdU staining was detected in the naïve (uninfected control) corneal
epithelium.
Furthermore, the number of BrdU+ cells were quantified using Image J software.
BrdU+ cells were counted per microscopic field (for a total of at least three different
fields/sample) at 20x magnification. A significant increase of BrdU labeling (average of
20 cells/microscopic field) in the basal and suprabasal layer of corneal epithelium at day
9 post-infection was detected, compared to the day 5 post-infection which showed few
(<10 cells/microscopic field) BrdU labeled cells at the basal layer of the corneal
epithelium. Nearly a 2-fold increase in BrdU labeling was observed in the corneal
epithelium at day 9 post-infection compared to day 5 post-infection. No BrdU+ cells
were detected in the naïve corneal epithelium (Figure 31 B). Thus, we infer from our
results that hyperproliferation is prominent due to the rapid cell turn over in the corneal
epithelium during the clinical onset of HSK disease.
Trans-differentiation of corneal epithelium during the clinical phase of HSK
In support with our previous data (Figure 30) that showed ocular surface
damage, we were further interested to study whether the corneal epithelial phenotype is
preserved during ocular HSV-1 infection. To study the corneal epithelial integrity, we
sought to investigate the cytokeratin expression pattern in the corneal epithelium of
HSV-1

infected

eyes

(at

day-4,

-10,

and

-16

post-infection)

by

using

immunofluorescence staining for K12 cytokeratin. K12 is specifically expressed on the
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corneal epithelium. Tile scan image of the corneal section at day-post infection showed
the loss of K12 expression, except few regions of the paracentral cornea expressed K12
(Figure 32). In the uninfected control (Figure 32), K12 expression was observed all
through the corneal epithelium in a uniform pattern. Since studies have shown that
pathological conditions transform the cytokeratin expression pattern of corneal
epithelium to ‘skin like epithelium’ [282] we further explored to identify epidermis like
phenotype in the corneal epithelium. To do this, we carried out immunofluorescence
staining for K10 cytokeratin in the HSV-1 infected eyes at day-4, -10, and -16 postinfection. Surprisingly, we detected an intense expression of K10 in the corneal
epithelium on day 10 and day 16 post-infection (Figure 33 G, H). Moderately stained
regions of K10 expression were visible at day 4 post-infection (Figure 33 F), while no
K10 stained regions were detected in the naïve (uninfected control) (Figure 33 E).
Notably, a dramatic loss of K12 staining was observed at day -10, and -16 post-infect
tion (Figure 33 C, D), while prominent staining of K12 was observed in the naïve (Figure
33 A). Collectively, our results showed a remarkable observation of phenotypic changes
in the corneal epithelium during HSV-1 infection. The occurrence of ‘transdifferentiation’
of corneal epithelium is evident from our data indicating a switch from non-keratinized to
a ‘keratinized skin like’ epithelium during the clinical disease phase of HSK (Figure 35).
Loss of PAX-6 expression in the corneal epithelium during the clinical phase of
HSK
A characteristic feature of corneal epithelium is the expression of transcription
factor Pax-6. Expression of Pax-6 in the corneal epithelium distinguishes it from the
epidermis and has a key role in exclusively eye development and morphogenesis [283].
As aforementioned our results showed trans-differentiation of corneal epithelium that
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showed loss of K12 expression in the HSV-1 infected cornea epithelium (Figure 32).
Expression of K12 is specific to the corneal epithelium. Therefore, to further investigate
whether the corneal epithelial phenotype is maintained in HSV-1 infected corneas, we
carried out immunofluorescence staining with the anti-Pax-6 antibody. The frozen
corneal sections from the naïve (uninfected control), at day -4, and -10 post-infection
were used for staining with an anti-Pax-6 antibody, followed by confocal image
acquisition. Remarkably, our results showed a dramatic loss of Pax-6 in the corneal
epithelium during the clinical disease phase of HSK (at day -10, -16 post-infection)
(Figure 34 G-L). In contrast, a predominant distribution of positively stained Pax-6 in the
nucleus was observed throughout the corneal epithelium in naïve and at day 4 postinfection (Figure 34 A-F). Here in, our results confirm the loss of corneal epithelial
identity and the loss of differentiation in the ocular surface lineage.
Discussion
In this study, we investigated a novel phenomenon on alterations of the corneal
epithelium and its trans-differentiation into ‘skin-like epithelium’ in HSV-1 infected eyes,
which is havoc to clear vision. The results from our study show the existence of dry eye
associated with corneal epithelial damage, K12-/K10+ expression and the loss of Pax6
expression in the corneal epithelium of the HSV-1 infected eyes.
The existence of a healthy, smooth and lubricated corneal surface is critical for
the maintenance of transparent cornea to aid clear vision. An intact cornea epithelium
not only functions as a protective barrier but also aids in tear production and its
maintenance. Consequently, this helps in keeping the ocular surface moist and healthy.
However, during dry eye condition, ocular surface damage has been reported [276]. Our
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data showed the existence of corneal epithelial damage via positive staining of Rose
bengal with reduced corneal smoothness in HSV-1 infected eyes. Rose Bengal (RB) is
widely known to diagnose dry eye conditions in the clinics. It is known that binding of RB
is prominent in the regions with altered mucin layer on the ocular surface or with ocular
surface damage [284]. Moreover, our results previously (Figure 25 A) showed reduced
tear volumes in HSV-1 infected eyes that may also influence ‘desiccating’ ocular
surface. In the mouse model of ‘desiccating dry eye,’ increased epithelial cell
proliferation was observed [276]. Our results showed a similar outcome with increased
proliferation in the corneal epithelium during HSV-1 infection determined by a positive
BrdU staining. Of note, a phenomenon of ‘hyperplasia’ may be occurring due to the
rapid turn-over of the cells and to compensate the damage in the corneal epithelium of
HSV-1 infected eyes. Altogether, these results indicate the occurrence of ocular surface
damage causing ‘dry eye’ conditions. Importantly, the increase in tear osmolarity has
been detected in dry eye diseases which eventually induces corneal epithelial damage
[285,286]. Thus, may pose a severe impact on preserving the corneal epithelial
integrity.
The expression of cytokeratin is crucial in maintaining the integrity of the corneal
epithelium [287] Hence, cytokeratin proteins have been widely used in elucidating
epithelial phenotype and its differentiation. Corneal epithelium comprises nonkeratinized stratified squamous epithelium. Cumulative studies have reported the
specific expression of K3 and K12 cytokeratin in the normal corneal epithelium
[288,71,289,290].

Nevertheless,

under

pathological
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non-keratinized

epithelium transforms into a keratinized epithelium that closely matches the features of
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skin epithelium (epidermis). The keratin expression profile determines this switch in
keratinization in the cornea. Typically, as previously mentioned K3/K12 are the keratins
that are specific to the corneal epithelium, which is replaced by epidermis-specific
K1/K10 expression under pathological conditions [282]. Intriguingly, our results showed
the loss of K12 expression concomitant to the gain of K10 expression the corneal
epithelium at day 10 and day 16 post-HSV-1 ocular infection. This suggests an
occurrence of transformation or trans-differentiation in the corneal epithelium during the
clinical stage of HSK disease progression (Figure 35).
Additionally, Pax-6 is a prominent marker of ocular surface lineage and has a
crucial role in the maintenance, regulation, and differentiation of corneal epithelium
[291]. Nonetheless, mouse model studies have showed that Pax6+/- mice are prone to
have brittle corneal epithelium [292]. Cumulative evidence from the reports have
indicated that the corneal epithelium in Pax6+/- mice displayed an improper
differentiation and maturation of the corneal epithelium. [293,279] Intriguingly, our data
showed a dramatic loss of Pax-6 in the corneal epithelium during the clinical disease
phase of HSK (at day 10 and day 16 post HSV-1 ocular infection). The loss of Pax-6 is
known to induce upregulation of epidermis-specific expression of cytokeratin (K1/K10)
in the corneal epithelium via a ‘default differentiation pathway’ [283] Several ocular
disease disorders such as Stevens-Johnson syndrome, Sjogren's syndrome, and dry
eye have reported a reduced expression of Pax-6 in association to the loss of K12,
increased K10 expression and increased proliferation in the corneal epithelium [294].
Moreover, Pax-6 expression is known to be interconnected with the K12 expression,
since Pax-6 stimulated the K12 promoter action [295]. In support, our results showed
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the loss of K12 with the emergence of K10, increased proliferation, and the loss of Pax6 in the corneal epithelium during the clinical disease phase of HSK. Altogether, it can
be concluded that Pax-6 is a key player in driving the ocular surface phenotype and in
the development of corneal epithelium. The members of Wnt pathway play an essential
role in signaling Pax-6 and K12 expression in the normal cornea [282] Henceforth, it will
be interesting to further explore the factors related to the loss of Pax-6 in the corneal
epithelium of HSV-1 infected eyes.
In conclusion, our results confirm the transformation in corneal epithelium leading
to the loss of corneal epithelial identity. ‘Squamous metaplasia’ is a phenomenon
characterized by an abnormal differentiation of corneal epithelium into the skin like
epithelium [296]. It is considered as a hallmark in Sjogren’s syndrome and StevensJohnson syndrome [296,297] Notably, one of the characteristic features of squamous
metaplasia include the loss of K3/K12 and the appearance of K1/K10 in the corneal
epithelium [271,272]. A recent study has reported the occurrence of epithelial to
mesenchymal transition (EMT) in HSV-1 infected corneas [298]. Overall, this evidence
supports our study to hypothesize that, the process of squamous metaplasia may likely
be occurring in the corneal epithelium of HSV-1 infected corneas.
Taken together, this study provides a comprehensive guide to indicate corneal
epithelial damage and transdifferentiation in the corneal epithelium of HSV-1 infected
eyes.
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Figure 30: Irregular corneal smoothness and damage to the ocular surface in the HSV-1 infected
eyes. A. The top panel shows eye images with corneal smoothness scores. From left, naïve eyes
showing a score of 0; at day 4 post-infection showing a score of 1; at day 10 post-infection showing a
score of 5. Corneal smoothness scores were recorded depending on the reflected ring structure on the
corneal surface. The intact round ring structure (naïve) signifies a corneal surface, in contrast to a
distorted ring structure that signifies a defective/irregular corneal surface (day 10 post-infection). The
bottom panel shows eye images stained with Rose Bengal (RB) staining. From left, naïve eyes showing
no positive staining of RB; at day 4 post-infection with faint staining of RB indicated by arrows; at day 10
post-infection with a prominent magenta/dark pink punctate stained area indicated by arrows. B. Bar
graphs show the corneal smoothness in the naïve, at day-4, -8, and -10 HSV-1 infected eyes. The data
were pooled from three independent experiments with n=4-6 eyes per group/experiment. The p values
ns

were calculated using one-way ANOVA (** p≤0.01, p>0.05).
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Figure 31: Hyperproliferation of the corneal epithelium during the clinical onset of HSK. A.
Representative immunofluorescence tile scan images of the frozen corneal sections stained with antiBrdU antibody in the naïve, at day -5, and -9 post-infection. Areas showing prominent BrdU staining
(colocalized with nuclear staining) is shown in the insets at a higher magnification (x400). Tile scan
images were acquired at x200 magnification. DAPI (red, nuclear staining), BrdU (green). B. Bar graphs
showing the quantification of BrdU+ cells in the naïve, at day -5, and -9 post-infection. Image J software
was used for quantification. Statistical analysis was performed by using unpaired two-tailed Student’s ttest (** p≤0.01, *p≤0.05).
.
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Figure 32: Loss of K12 expression the corneal epithelium during the clinical disease of
HSK. Representative immunofluorescence tile scan images shown with anti-K12 staining in the
naïve cornea (top panel) and at day 10 post-infection (bottom panel). The naïve corneal tile scan
image shows an intense membrane staining of K12 throughout the entire corneal epithelium. The
insets (A,B) shows magnified images (x400 magnification) of the K12 staining. The day 10 postinfection corneal tile scan image shows loss of K12. K12 staining is not observed throughout the
corneal epithelium. The insets (C,D) shows magnified images showing the areas with loss of K12
staining. Tile scan images were acquired at x200 magnification. DAPI (blue, nuclear staining),
K12 (green). Immunofluorescence images shown are representative of three corneas at each
time-point.
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Figure 33: Loss of K12 expression and the gain of K10 expression in the corneal epithelium during
the clinical disease of HSK. Representative immunofluorescence images of frozen corneal sections
stained with K12 (A-D); K10 (E-H). K12 is a corneal epithelial specific cytokeratin that shows intense
staining in the naïve corneal epithelium (A) and progressively disappears at day 4 (B) showing patchy
K12 staining; at day 10 (C) shows loss of K12, only small regions in the corneal epithelium show K12
staining; at day 16 (D) No staining or the loss of K12) detected. K10 is an epidermis (skin) specific
cytokeratin that shows prominent K10 staining at day 10 (G) and at day 16 (H); while a patchy staining
pattern of K10 is observed at day 4(F); No K10 staining is observed in the naïve (control, E).
Magnification x200. DAPI blue- nucleus staining, K12- green {A-D}. DAPI red- nucleus staining, K12green {E-H}. Immunofluorescence images shown are representative of three corneas at each time-point.
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Figure 34: Loss of Pax-6 expression in the corneal epithelium during the clinical disease of HSK.
Representative immunofluorescence images of frozen corneal sections showing Pax-6 (green) DAPI (in
red), and the merged images with nuclear localization of Pax-6 (in yellow). Pax-6 staining in the naïve (AC), prominent staining in the nucleus observed as shown in the insets with the zoomed image. At day 4
post-infection (D-F), prominent staining in the nucleus observed as shown in the insets with zoomed
images. At day 10 post-infection (G-I), loss of Pax-6 expression observed. At day -16 post-infection (J-L),
loss of Pax-6 observed. Magnification X400. Immunofluorescence images shown are representative of
three corneas at each time-point.
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Figure 35: A schematic representation to depict alterations of cytokeratin expression in the corneal
epithelium during the clinical disease period.
This diagram shows the process of trans differentiation in the corneal epithelium of HSV-1 infected eyes.
A loss of K12 expression (corneal epithelial specific) to the gain of the epidermis (skin) specific K10
expression is detected in the corneal epithelium of HSV-1 infected eyes during the clinical disease phase
of HSK.
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Figure 36: A proposed model to summarize the events of ocular surface alterations in HSV-1
infected cornea during the clinical disease period. This model emphasis on the impact of reduced tear
levels observed in the HSV-1 infected cornea.
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CHAPTER 4: IGF-1 DEPENDENT MECHANISM OF IGFBP-3 IN THE
PATHOGENESIS OF HERPES STROMAL KERATITIS
Abstract
Herpes Stromal Keratitis (HSK) is a chronic immunoinflammatory condition that
develops in response to recurrent corneal infection with herpes simplex virus-1 (HSV-1)
and is considered a major cause of infection-induced blindness in the United States.
Clinical manifestations of HSK involve the development of angiogenesis and opacity
into the avascular cornea. A better understanding of immunoinflammatory events that
promote angiogenesis and opacity in infected cornea could provide novel therapeutic
targets to treat HSK. IGFBP-3 binds to 75% of serum IGF proteins and regulates their
bioavailability and IGF-1R signaling. The latter is known to enhance angiogenesis and
immune cell survival and effector function. An elevated level of IGFBP-3 protein was
detected in HSV-1 infected corneas while carrying out angiogenic protein array in
infected corneal samples from C57BL/6 (B6) mice. To determine the role of IGFBP-3 in
the pathogenesis of HSK, B6 and IGFBP-3-/- mice received corneal HSV-1 infection.
Our results showed a significant increase in hem-angiogenesis and opacity scores in
infected corneas of IGFBP-3-/- than control B6 mice. IGFBP-3 may exert its protective
effect by sequestering IGF molecules and reducing IGF-1R mediated signaling. In
support, our results showed increased phosphorylation of IGF-1R expressing
leukocytes in infected corneas of IGFBP-3-/- mice. This was associated with an
increased number of granulocytes in HSK lesions of IGFBP-3-/- than B6 mice. IGFBP-3
is known to undergo proteolysis by matrix metalloproteinase-3 (MMP-3), releasing
bioactive IGF molecules. Previous reports from our laboratory detected an
enzymatically active MMP-3 (by Zymography) in B6 corneas with HSK. Together, our
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results suggest that IGFBP-3 is likely exerting a protective effect since their absence
causes an increase in opacity and robust hem-angiogenesis in infected corneas.
IGFBP-3, in IGF-dependent mode, regulates the pathogenesis of HSK.
Introduction
IGFBP-3 is one of the six highly conserved Insulin Growth Factor (IGF)-binding
proteins that bind to 75% of the serum IGF proteins to form complexes and regulates
IGF-1R signaling by sequestering IGF molecule. Indeed, IGFBP-3 helps in regulating
the bioavailability of IGF proteins and IGF-1R mediated signaling [299,300,154] IGF
binding to IGF-1R results in phosphorylation of tyrosine residues in IGF-1Rβ and
thereby initiates IGF-1R signaling [301,157]. IGF-1R signaling is reported to initiate
hem- and lymphangiogenesis and promote survival of immune cells [302,303,304,305]
IGFBP-3 also acts in IGF-independent mode, which involves cell surface binding,
cytosolic accumulation and nuclear localization of IGFBP-3 [306]. IGF-dependent and
independent action of IGFBP-3 is known to regulate hem-angiogenesis [307,184]. In
this study, we investigated the contribution of IGF dependent action IGFBP-3 and its
role in immune survival and pathogenesis of HSK in a mouse model.
Development of hem-angiogenesis is the hallmark of HSK in HSV-1 infected
cornea [308]. Our interest was to ascertain the levels of protein expression involved in
regulating hem-angiogenesis in HSV-1 infected cornea. An elevated level of IGFBP-3
protein was detected in HSV-1 infected corneas by using a membrane-based mouse
angiogenesis array in HSV-1 infected mouse cornea (Figure 37 A). Previous studies
have shown that IGFBP-3 can either promote or inhibit hem-angiogenesis
[309,141,310]. Therefore, we next evaluated the role of IGFBP-3 in the pathogenesis of
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HSK by infecting both, the B6 and IGFBP-3-/- mice with corneal HSV-1 infection. Our
results showed a significant increase in hem-angiogenesis and opacity scores in
infected corneas of IGFBP-3-/- than control B6 mice (Figure 40 B). As aforementioned,
binding of IGFBP-3 to IGF likely exerts its protective effect by sequestering IGF
molecules and by reducing IGF-1R mediated signaling. Notably, these results
associated with an increased influx and enhanced phosphorylation of IGF-1R
expressing leukocytes in infected corneas of IGFBP-3-/- mice (Figure 39). Apart from
this, IGFBP-3 is also well known to undergo proteolysis during pathological conditions
such as diabetes, arthritis, and cancer by matrix metalloproteinases (MMPs) and may
release the bound IGF molecules. MMP-3 and MMP-9 have been reported to involve in
the proteolysis of IGFBP-3 in inflamed tissue [167]. Intriguingly, previous data from our
lab showed a significant increase in the enzymatically active MMP-3 and MMP-9, which
was detected by Zymography. From this, we conclude that the active mechanism of
IGFBP-3 might have been compromised in the presence of proteases which cleaves the
IGFBP-3 molecule. Therefore, this results in the increased hem-angiogenesis and
opacity scores in the corneas of HSV-1 infected IGFBP-3-/- mice. Overall, our results
suggest that IGFBP-3, in IGF-dependent mode, regulates the pathogenesis of HSK.
In summary, IGFBP-3 plays a defensive role by binding to IGF-1 and thereby
inhibits IGF-1R phosphorylation that signals to promote hem-angiogenesis in HSV-1
infected cornea. In support to this, our results have also shown a possible protective
role of IGFBP-3 in inhibiting IGF-1R signaling (phosphorylation) and thereby, the
development of hem-angiogenesis in HSV-1 infected cornea during the clinical onset of
HSK disease.
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Results
An Increased level of IGFBP-3 protein and mRNA expression in HSV-1 infected B6
corneas
Development of corneal opacity and neovascularization in an avascular cornea is
the hallmark of HSK [308]. Primarily, the objective of this study was to understand the
underlying mechanisms involved in the pathogenesis of HSK. Hence, a membranebased angiogenesis array was performed (as described in materials and methods) to
detect the level of angiogenesis-regulating proteins in the corneal lysates of uninfected
(naïve) and at day -5, -10, and -15 post-HSV-1 infection. Interestingly, our results
showed an increased pixel density of IGFBP-3 in HSV-1 infected corneas (Figure 37 A).
The pixel density was determined by using the Image studio lite software. We further
sought to confirm this result by performing ELISA and qRT-PCR assay to estimate the
IGFBP-3 protein and mRNA levels of IGFBP-3 in HSV-1 infected corneas, respectively.
A Significant increase in, mRNA levels of IGFBP-3 gene (Figure 37 B) and the IGFBP-3
protein expression (Figure 37 C) and was detected in the HSV-1 infected corneas
during the clinical disease phase of the HSK disease (day -10 and -15 post infection,
respectively) when compared to the corneas during pre-clinical phase of HSK disease
(day 5 post-infection).
Furthermore, our angiogenesis protein array data (Figure 37 A) showed an
increased level of matrix metalloproteinase-3, and -9 (MMP-3, -9) in infected corneas
with HSK. Recently, the zymography data from our lab also confirmed the enzymatic
activity of MMP-3 in HSK corneas (data not shown). Collectively, these results provoked
us to focus on the role of IGFBP-3 protein in the pathogenesis of HSK and to further
study the impact of MMP-3, -9 on IGFBP-3.
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A significant increase in IGF-1R phosphorylation detected in total leukocytes
present in HSK developing corneas of IGFBP3-/- than the control C57BL/6 (B6)
mice
IGFBP-3 under specific conditions has been reported to either promote or inhibit
hem-angiogenesis [309,307,184] Furthermore, IGFBP-3 is known to exert their function
via insulin-like growth factor (IGF)-dependent and -independent mechanisms (Figure 7).
IGF-dependent activity includes sequestration of IGF-I, and -II proteins and thereby
regulates their bioavailability to the cell surface IGF-1 receptor (IGF-1R) [153]. IGF
molecules bind to the IGF-receptor to mediate its autophosphorylation. Subsequently,
downstream signaling events occur to initiate the process of hem-angiogenesis,
immune cell survival and effector function [304,305,311] (Figure 38A). However,
proteolysis of IGFBP-3 can induce enhanced IGF signaling, due to an increased
IGF/IGF-R interaction [166,312]. A study from our laboratory has shown an increased
expression of MMP-3 and its enzymatic activity detected in HSV-1 cornea. In support,
our protein array data (Figure 37 A) also showed higher levels of MMP-3 and MMP-9 in
HSV-1 infected corneas. Several reports have suggested that in inflamed tissue, MMPs
are involved in the proteolysis of IGFBP-3 [168,167] Taken together, we hypothesized
that active IGF-1R signaling might be induced due to increased expression of MMPs,
that leads to the IGFBP-3 proteolysis in HSV-1 infected corneas.
Concerning this, our foremost interest was to study the phosphorylated
(activated) IGF-1R expression in the HSV-1 infected corneas of B6 mice.
Immunofluorescence staining of the frozen corneal section showed positive staining for
phosphorylated IGF-1R (pIGF-1R) in the HSV-1 infected B6 cornea at the clinical
disease phase of HSK (day -10 and -17 post-infection) compared to the naïve (Figure
38 B). IGF-1R staining was carried out in the frozen corneal section by using the anti-
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IGF-IR antibody (Table 1) that distinguishes the phosphorylated tyrosine 1161 (pY1161)
in the IGF-1 receptor. Intense staining was detected explicitly in the corneal stroma of
HSV-1 infected eyes at day 17 post-infection (Figure 38 B). This result suggests active
IGF-1R signaling in the corneas of the HSV-1 infected eyes of B6 mice.
To further quantitate the IGF-1R phosphorylation and to study the IGF dependent
action of IGFBP-3, we opted to use IGFBP-3 -/- mice in this study. The IGFBP-3

-/-

mice

on the B6 background [313] were provided by Dr. Steinle laboratory as mentioned in
Materials and Methods. Quantification of IGF-1R phosphorylation was determined by
employing flow cytometry analysis in IGFBP-3

-/-

and the control B6 HSV-1 infected

mice. Our data showed a significant increase in the frequency of CD45+ cells
(leukocytes) and an absolute number of CD4+ T cells in IGFBP-3 -/- than the B6 mice on
day 10 post-infection (Figure 39 A, B). Intriguingly, a significant increase in the IGF-1R
phosphorylation at tyrosine residue 1131 (pY1131) was detected in leukocytes (CD45+
cells) infiltrating HSK corneas in IGFBP-3

-/-

than the B6 mice on day 10 post-infection

(Figure 39 C).
Notably, these results suggest an increased immune cell influx and active IGF-1R
signaling in leukocytes infiltrating IGFBP-3 -/- mice in HSK corneas. Moreover, this study
provides us the cues on IGF dependent action of IGFBP-3 in HSV-1 infected corneas.
Development of robust HSK disease with a significant increase in hemangiogenesis and corneal opacity in HSV-1 infected eyes of IGFBP3-/- than the
control B6 mice
Upon understanding the existence of active IGF-1R signaling in leukocytes
infiltrating HSV-1 infected IGFBP-3

-/-

mouse corneas, we were next inclined to

determine the role of IGFBP-3 in regulating the severity of HSK. Active IGF-1R signaling
is known to promote hem-angiogenesis and enhance inflammation [304,311,314].
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Therefore, we were prompted to hypothesize that, HSV-1 infected IGFBP-3

-/-

mouse

corneas may display a severe HSK disease. To test this, B6 and IGFBP-3

-/-

HSV-1

infected mouse corneal opacity, and hem-angiogenesis scores were assessed by using
a hand-held slit lamp as described in Materials and Methods. As expected, our results
showed a robust HSK disease in the IGFBP-3

-/-

than the B6 HSV-1 infected mouse

corneas (Figure 40 A). A significant increase in the corneal opacity and hemangiogenesis scores were evaluated in the HSV-1 infected corneas of IGFBP-3

-/-

mouse corneas during the clinical disease phase of HSK (at day-10, and -12 postinfection) (Figure 40 B). Together, these results suggest that IGFBP-3 plays an
essential role in governing the severity of HSK.
Discussion
Corneal hem-angiogenesis and associated immunoinflammatory events in HSV1 infected cornea are the prominent features of HSK [234,108]. Hence, a better
understanding of the molecules involved in the regulating angiogenesis, immune cell
survival and effector function in HSK corneas is essential. Our results from the
angiogenesis array data showed an increased expression of IGFBP-3 in HSV-1 infected
corneas (Figure 37 A). IGFBP-3 under specific conditions has been reported to either
promote or inhibit hem-angiogenesis [309,307,184,310]. Notably, an increased hemangiogenesis and massive influx of leukocytes were detected in the HSV-1 infected
corneas of IGFBP-3

-/-

than the B6 infected mice. This indicates an essential role of

IGFBP-3 in the pathogenesis of HSK.
Interestingly, our angiogenesis array data showed an increased expression of
MMP-3 and -9 in HSV-1 infected corneas in B6 mice (Figure 37 A). MMP-3 is known to
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cause proteolysis of IGFBP-3 [167,165,166]. MMP-3 and -9 are reported to trigger
proteolysis of IGFBP-3 resulting in the in the enhancement of the IGF- mediated actions
[166,165,167]. In the mouse model of HSK, the expression and activity of MMP-9 have
been reported in HSV-1 infected corneas [170]. MMP-3 serves as an activator of proMMP-9 and is involved in the generation of an active form of MMP-9 [171]. Thus, in
HSK corneas, MMP-3 may regulate the effect of MMP-9 and more importantly in the
proteolysis of IGFBP-3.
The mechanism of action of IGFBP-3 can either be in an IGF-dependent or
independent manner. Briefly, IGF- dependent action is executed by sequestration of
IGF-I and II proteins and thereby modulating their bioavailability to cell-surface IGF-1
receptor (IGF-1R). IGF-independent action involves cell surface binding of IGFBP-3 and
its cytosolic or nuclear localization [179,153]. The aim of this study was to determine the
IGF dependent action of IGFBP-3. Since IGF molecules get complexed with IGFBP-3,
the proteolysis of IGFBP-3 in HSV-1 infected cornea may liberate IGF molecules.
Subsequently, the liberated IGF molecules can bind to IGF-1R which indeed can lead to
enhanced activation of IGF-1R signaling (autophosphorylation of IGF-1R). Our results
showed an intense staining for phosphorylated IGF-1R (IGF-1R, Tyr1161) in HSV-1
infected B6 corneas during the clinical disease period (day-10, -17 post -infection)
(Figure 38).

This suggests active IGF-1R signaling, which could be due to the

proteolysis of IGFBP-3 by enzymatically active MMP-3.
IGF-1R signaling has been widely reported to have pleiotropic effects, which
include enhancing cell proliferation and migration, promoting hem-angiogenesis,
immune cell survival and its effector function [314,160,304,305]. In support, our results

132
showed enhanced IGF-1R phosphorylation in infiltrating leukocytes of HSV-1 infected
IGFBP-3

-/-

mice than the B6 mice (Figure 39). A robust development of HSK disease

was observed with increased corneal opacity and hem-angiogenesis in the HSV-1
infected IGFBP-3

-/-

mice than the B6 mice (Figure 40). These results elucidate the

involvement of MMP-3 in the proteolysis of IGFBP-3 which consequently leads to
activated signaling of the IGF receptor and its adverse effect on HSK disease severity.
To further ensure the role of IGFBP-3 in HSK pathogenesis and its IGF
dependent mechanism, an approach to block IGF-1R phosphorylation was carried out in
HSV-1 infected mice. PPP inhibits IGF-1R phosphorylation in a non-ATP competitive
manner [316].
In this study, we deciphered the role of IGFBP-3 in HSK developing corneas that
may provide cues for novel therapeutic targets and reduce HSK disease severity.
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Figure 37: A. Increase in IGFBP3 protein expression in C57BL/6 mouse corneas at different time
points post-ocular HSV-1 infection. A. Images showing angiogenesis array blots of corneal lysates
prepared from the naïve and HSV-1 infected cornea at day 5, 10 and 15 post-ocular infections. Bar
diagram on the right showing the quantification of dots represented as signal intensity of IGFBP3, MMP-3,
MMP-9 and TIMP-1 using image studio lite software. MMPs -Matrix metalloproteinases, and TIMPsTissue inhibitor of Matrix Metalloproteinases. B. Scatter plot showing the relative mRNA expression of
IGFBP3 in HSV-1 infected B6 mouse corneas at day 5 and 10 post infection (DPI). C. Bar graph showing
the protein levels of IGFBP-3 using ELISA in HSV-1 infected B6 mouse corneas at day 5 and day 15
post-infection.
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FIGURE 38: Intense IGF-1R staining in HSV-1 infected C57BL/6 (B6) mouse cornea during the
clinical disease period. A. schematic of proposed mechanism hypothesizing active IGF-1R signaling by
binding to IGF molecule to initiate Tyr-kinase phosphorylation (pY1161). Increased IGF-1R
phosphorylation may promote hem-lymph angiogenesis and Immune cell survival. B. From the left
showing frozen naïve corneal tissue section of B6 mice with no prominent IGF-1R staining, on day 10
post-infection showing prominently in the corneal epithelium and the stroma, on day 17 post-infection
showing intense IGF-1R staining in the corneal stroma. DAPI staining nucleus in blue; pIGF-1R detecting
phosphorylated IGF-1R (pY1161) in green. Magnification x400.
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Figure 39: Significant increase in IGF-1R phosphorylation detected in total leukocytes in HSK
developing corneas of IGFBP-3-/- in comparison to the C57BL/6 mice. A. Representative FACS plots
are denoting the frequency of leukocytes in HSV-1 infected cornea from the B6 and IGFBP-3 KO mice at
day10 post-ocular infection (POI). B. Scatter plot is showing a significant increase in the frequency of
CD45+ cells in IGFBP-3KO mice than the B6 on day 10 POI. Bar graph is showing a significant increase
in the absolute number of CD4+ T cells in IGFBP-3KO mice than the B6 on day 10 POI. C. Overlay
depicts the higher levels of phosphorylated IGF-1R in infected corneas of IGFBP-3 KO compared to the
B6 mice. The scatter plot on the right showing a significant increase in Mean fluorescence intensity (MFI)
of the phosphorylated IGF-1R in the total leukocytes present in the infected corneas of IGFBP3-KO mice
than the B6 on day10 POI. Results shown are representative of two similar experiments. (n=5 to 8 eyes
per group) p values were calculated using two-tailed t-test. **p≤0.01, ***p≤0.001, ***p≤0.0001
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Figure 40: Robust development of HSK disease in HSV-1 infected IGFBP-3-/- mice in comparison to
the C57BL/6 mice. A. Representative eye images of B6 and IGFBP-3-/- mice showing more severe
disease in the IGFBP-3KO mice with robust development of angiogenesis than in the B6 mice at day 10
and 12 post-ocular HSV-1 infections (POI) during the clinical disease of HSK. B. Scatter plots showing
corneal opacity scores and corneal angiogenesis scores at day 7, day 10 and day 12 post-HSV-1
infection, measured using a slit lamp. Both groups of mice were infected with a low dose of virus (10 to 4
p.f.u). Results shown are representative of two similar experiments. (n=5 to 8 eyes per group). p values
were calculated using two-tailed t-test. **p≤0.01, ***p≤0.001.
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Figure 41: Schematic Representation to summarize the Aims investigated in
this study in HSV-1 infected mouse corneas.
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Herpes stromal keratitis (HSK) is a chronic immuno-inflammatory ocular disease
caused by Herpes simplex virus-1 (HSV-1) infection in the cornea. HSK is characterized
by the development of corneal opacity and angiogenesis accompanied by the loss of
corneal transparency. Despite extensive studies on inhibiting corneal angiogenesis and
strategies to reduce HSK disease development, a key underlying mechanism to
maintain an intact and a transparent corneal surface during HSK disease progression,
remain obscure. Our study has addressed possible causes for the HSK disease severity
by identifying the key factors such as the development of inflammatory hypoxia,
reduced tear volume, Inflammation of extra-orbital lacrimal gland and the conjunctiva
and the transdifferentiation of the corneal epithelium in the HSK developing eyes.
Intriguingly, our study also emphasizes the protective role of IGFBP-3 in inhibiting the
severe disease progression of HSK.
During the pre-clinical and the clinical disease phase of HSK, the influx of
neutrophils have been studied as the most prominent innate immune cell type.
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Development of corneal hem- and lymph-angiogenesis, opacity and epithelial defects
hinders the clear vision and is known to be the cause of the increased neutrophil influx
in HSV-1 infected cornea. Previous studies have indicated that the influx of neutrophils
into mucosal tissue can re-model the development of inflammatory hypoxia. Therefore,
the aim of this study was to investigate the development of hypoxia and hypoxiaassociated gene expression during the progression of HSK disease. Our results showed
an increased influx of neutrophils during the clinical disease of HSK that leads to the
development of hypoxia, and the upregulation of hypoxia-associated genes. This study
provided us novel insights on the prevalence of the glycolytic metabolism in the HSK
developing eyes. Additionally, our data demonstrated that the blocking of HypoxiaInducible Factor (HIF) with Acriflavine alone might not be an efficacious drug in reducing
HSK disease severity. Overall, these results pave way for using novel therapeutic
targets that play a dual role to block HIF and control corneal inflammation during HSK.
Maintaining a healthy corneal epithelium, retaining a steady tear volume and its
secretion could be the other factors that may aid in alleviating HSK disease severity.
Mounting evidence corroborates corneal nerves as a critical factor in the maintenance
of corneal integrity and homeostasis of the ocular surface by mediating the reflex
actions of blinking and tearing. In support, in a mouse model during HSV-1 ocular
infection, corneal nerve damage has been demonstrated. Hence, corneal transparency
and clear vision are critically dependent upon the integrity of corneal tissue maintained
by the intricate network of corneal nerves, the presence of intact corneal epithelium and
tear film that is controlled by a cross-talk between the components of the lacrimal
functional unit. Our study showed a reduced measurement of tear volume in the HSK
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developing eyes correlating to the inflammation in the extra-orbital lacrimal gland
(EoLG) and the conjunctiva. Atrophy of tear secreting acinar cells in the EoLG, the
significant loss of goblet cells in the conjunctiva and the influx of leukocytes and CD4 T
cells were the major events occurring during the HSV-1 infection. These events caused
dysfunction to the lacrimal functional unit, thereby inducing severe HSK and ‘dry eye’
conditions. Nevertheless, topical treatment of lacritin (tear glycoprotein) delayed but did
not prevent the reduction in tear volume nor reduced the severity of HSK.
Existence of a healthy, smooth and lubricated corneal surface is critical for the
maintenance of transparent cornea to aid clear vision. Corneal epithelium comprises of
non-keratinized stratified squamous epithelium. Nevertheless, under pathological
conditions non-keratinized epithelium transforms into a keratinized epithelium that
closely matches the features of skin epithelium (epidermis). The keratin expression
profile determines this switch in keratinization in the cornea. Cytokeratin-12 (K12) is one
of the keratins specific to the corneal epithelium, which is replaced by epidermis-specific
cytokeratin-10 (K10) expression under pathological conditions. Intriguingly, our data
showed the loss of K12 expression with the emergence of K10 expression during the
clinical stage of HSK disease. Our data suggested the occurrence of corneal epithelial
transformation. Another prominent marker, PAX-6 (paired box -6 transcription factor)
has a crucial role in the maintenance of corneal epithelial identity by regulation of its
differentiation. Our data showed a dramatic loss of PAX-6 expression in the HSK
developing eyes. ‘Squamous metaplasia’ is the pathological phenomenon characterized
by abnormal differentiation of corneal epithelium into the skin like epithelium. Overall,
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our results signified the ‘trans-differentiation of corneal epithelial cells to the skin like
epithelium, in HSV-1 infected mouse cornea.
Corneal hem-angiogenesis is one of the hallmarks of HSK. Hence, it is essential
to understand better the molecules involved in regulating hem-angiogenesis, immune
cell survival, and its effector function. Intriguingly, angiogenesis array data showed an
increased expression of IGFBP-3 in the HSV-1 infected corneas of C57BL/6 (B6) mice.
Therefore, we were inclined to study the role of IGFBP-3 molecule in HSV-1 infected B6
corneas. IGFBP-3 is one of the six highly conserved IGF-binding proteins. IGFBP-3
binds to 75% of the serum IGF-I and IGF-II in complexes and regulates IGF-1R
signaling by sequestering IGF molecule. IGF binding to IGF-1R results in
phosphorylation of tyrosine residues in IGF-1Rβ chain. IGF-1R signaling that has been
reported to promote angiogenesis (hem- and lymph-angiogenesis). Our data indicated
severe HSK disease with robust angiogenesis in IGFBP-3-/- mice associated with a
significant increase in IGF-1R phosphorylation in the infiltrated leukocytes. These
results suggest the protective role of IGFBP-3 in inhibiting IGF-1R phosphorylation that
leads to the development of severe HSK disease progression.
Altogether, this study broadens our knowledge on understanding several
factors involved in the alterations of the ocular surface system during the
pathogenesis of HSK. In summary, this study highlights on five crucial factors that
may play an essential role in reducing HSK disease pathogenesis in the cornea; 1)
regulating the development of inflammatory hypoxia 2) maintaining of the stable tear
volume 3) reducing the lacrimal and conjunctival inflammation 4) maintaining the
corneal epithelial integrity 3) alleviating corneal hem-angiogenesis (Figure 42).
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